pyrimethamine has been researched along with Anemia in 121 studies
Maloprim: contains above 2 cpds
Anemia: A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Coverage of antenatal iron and folic acid (IFA) supplementation and malaria chemoprophylaxis remains low in many low-income and middle-income settings." | 9.69 | Improving coverage of antenatal iron and folic acid supplementation and malaria prophylaxis through targeted information and home deliveries in Côte d'Ivoire: a cluster randomised controlled trial. ( Dao, D; Fink, G; Koné, S; Probst-Hensch, N; Utzinger, J, 2023) |
| "In 2003, Mali introduced intermittent preventive therapy in pregnancy (ITPp) with sulfadoxine-pyrimethamine (SP) for the control of malaria in pregnancy, consisting of 2 doses of SP given in the 2nd and 3rd trimester." | 9.15 | Superiority of 3 over 2 doses of intermittent preventive treatment with sulfadoxine-pyrimethamine for the prevention of malaria during pregnancy in mali: a randomized controlled trial. ( Bougoudogo, F; Coulibaly, S; Danis, M; Dara, A; Diakite, OS; Diallo, M; Djimde, A; Doumbo, OK; Doumbo, S; Doumtabé, D; Guindo, O; Karim, DM; Kayentao, K; Maiga, OM; Ongoiba, A; Ter Kuile, FO; Traoré, B; Traoré, BT; Traoré, M; Traoré, MS, 2011) |
| "In the context of a trial studying intermittent preventive sulfadoxine-pyrimethamine treatment of malaria in infants in Lambaréné, Gabon, children aged 18-30 months were followed up after having received their last dose at an age of 15 months." | 9.14 | No rebound of morbidity following intermittent preventive sulfadoxine-pyrimethamine treatment of malaria in infants in Gabon. ( Aponte, JJ; Borchert, LB; Doernemann, J; Gabor, JJ; Grobusch, MP; Issifou, S; Koester, KB; Kremsner, PG; Kurth, F; Lell, B; Poetschke, M; Pongratz, P; Profanter, K; Schuster, K; Schwarz, NG, 2009) |
| "The study design was an open randomized control trial comparing anaemia incidence among pregnant women on intermittent presumptive treatment of malaria with SP with those on chloroquine (CQ)." | 9.13 | Efficacy of intermittent preventive treatment of malaria with sulphadoxine-pyrimethamine in preventing anaemia in pregnancy among Nigerian women. ( Abiona, TC; Asa, OO; Fatusi, AO; Ijadunola, KT; Onayade, AA, 2008) |
| "Whether administration of folic acid to children with malaria anemia is helpful is controversial." | 9.12 | Folic acid treatment of Zambian children with moderate to severe malaria anemia. ( Bennett, S; Fielding, K; Greenwood, B; Malunga, P; Mulenga, M; Shulman, C; Thuma, P, 2006) |
| " We tested the hypothesis that artesunate-sulfamethoxypyrazine-pyrimethamine is as efficacious as the four-dose regimen of artemether-lumefantrine for treatment of Plasmodium falciparum malaria." | 9.12 | A randomized trial of artesunate-sulfamethoxypyrazine-pyrimethamine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali. ( Dicko, A; Djimde, A; Doumbo, OK; Fofana, M; Guindo, O; Jansen, HF; Kone, M; Ouattara, A; Sagara, I; Sissoko, M; Sogoba, M; Thera, MA; Tolo, Y, 2006) |
| "The World Health Organization advocates 2-3 doses of sulfadoxine-pyrimethamine (SP) for intermittent preventive treatment of malaria (SP IPTp)." | 9.12 | Inferiority of single-dose sulfadoxine-pyrimethamine intermittent preventive therapy for malaria during pregnancy among HIV-positive Zambian women. ( Chalwe, V; Champo, D; Chilengi, R; Gill, CJ; Hamer, DH; Macleod, WB; Mukwamataba, D; Mwanakasale, V; Mwananyanda, L; Thea, DM, 2007) |
| "The World Health Organization recommends intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine-pyrimethamine for malaria for all women who live in moderate to high malaria transmission areas in Africa." | 8.98 | Mefloquine for preventing malaria in pregnant women. ( Aponte, JJ; González, R; Menéndez, C; Piqueras, M; Pons-Duran, C; Ter Kuile, FO, 2018) |
| "In 2012 the World Health Organisation (WHO) revised the policy on Intermittent Preventive Treatment with Sulphadoxine Pyrimethamine (IPTp-SP) to at least three doses for improved protection against malaria parasitaemia and its associated effects such as anaemia during pregnancy." | 8.02 | Intermittent preventive treatment comparing two versus three doses of sulphadoxine pyrimethamine (IPTp-SP) in the prevention of anaemia in pregnancy in Ghana: A cross-sectional study. ( Agyeman, YN; Annor, RB; Newton, S; Owusu-Dabo, E, 2021) |
| " Structured interview and antenatal clinic cards were used to obtain data including the use of intermittent preventive therapy in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP)." | 7.91 | Adverse birth outcomes among mothers who received intermittent preventive treatment with Sulphadoxine-Pyrimethamine in the low malaria transmission region. ( Aklillu, E; Kamuhabwa, AAR; Mikomangwa, WP; Oms, M, 2019) |
| "To investigate whether high-dosed folate supplements might diminish the efficacy of malaria intermittent preventive treatment in pregnancy (IPTp) with sulphadoxine-pyrimethamine (SP) in a cohort of pregnant women in Benin, where malaria is holoendemic." | 7.88 | High folate levels are not associated with increased malaria risk but with reduced anaemia rates in the context of high-dosed folate supplements and intermittent preventive treatment against malaria in pregnancy with sulphadoxine-pyrimethamine in Benin. ( Accrombessi, M; Cot, M; Moya-Alvarez, V; Ouédraogo, S, 2018) |
| "The impact of sulfadoxine-pyrimethamine (SP) used as intermittent preventive treatment during pregnancy (IPTp-SP) on mutant parasite selection has been poorly documented in Burkina Faso." | 7.85 | Recent uptake of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine is associated with increased prevalence of Pfdhfr mutations in Bobo-Dioulasso, Burkina Faso. ( Awandare, GA; Cisse, M; Guiguemdé, RT; Hayette, MP; Soulama, A; Tinto, H, 2017) |
| "Effectiveness of cotrimoxazole (CTX) compared with sulfadoxine-pyrimethamine (SP) intermittent-preventive-therapy (IPTp) for malaria in HIV-infected pregnant women is unknown." | 7.77 | Marked reduction in prevalence of malaria parasitemia and anemia in HIV-infected pregnant women taking cotrimoxazole with or without sulfadoxine-pyrimethamine intermittent preventive therapy during pregnancy in Malawi. ( Fitzgerald, M; Kapito-Tembo, A; Meshnick, SR; Mwapasa, V; Phiri, K; van Hensbroek, MB, 2011) |
| "To assess the effect of intermittent preventive treatment with sulfadoxine and pyrimethamine (IPT-SP) on placental parasitemia and maternal and perinatal outcome." | 7.77 | Efficacy of intermittent preventive treatment with sulfadoxine-pyrimethamine on placental parasitemia in pregnant women in midwestern Nigeria. ( Akubuo, KK; Aziken, ME; Gharoro, EP, 2011) |
| "The effectiveness of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine (IPTp-SP) against malaria and anemia is unclear because of the spread of SP-resistant Plasmodium falciparum." | 7.77 | Intermittent preventive treatment with sulfadoxine-pyrimethamine against malaria and anemia in pregnant women. ( Adjei, AA; Anderson, WA; Ceesay, FK; Gyasi, RK; Lucchi, NW; Ndjakani, Y; Obed, SA; Rodney, P; Stiles, JK; Wilson, NO, 2011) |
| "To evaluate the impact of a 2-year programme for community-based delivery of sulfadoxine-pyrimethamine (SP) on intermittent preventive treatment during pregnancy coverage, antenatal clinic attendance and pregnancy outcome." | 7.75 | Community-based distribution of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy improved coverage but reduced antenatal attendance in southern Malawi. ( Brabin, BJ; D'Alessandro, U; Gies, S; Kalanda, G; Kazembe, PN; Msyamboza, KP; Savage, EJ, 2009) |
| "To appraise the prevalence of malaria and anaemia in antenatal mothers; and explore the factors influencing coverage of intermittent preventive treatment (IPT) with sulfadoxine-pyrimethamine (SP) under operational conditions in the national programme for malaria control in pregnancy." | 7.74 | Appraisal on the prevalence of malaria and anaemia in pregnancy and factors influencing uptake of intermittent preventive therapy with sulfadoxine-pyrimethamine in Kibaha district, Tanzania. ( Tarimo, SD, 2007) |
| "In 1993, Malawi introduced sulphadoxine-pyrimethamine (SP) for the treatment of uncomplicated, Plasmodium falciparum malaria and became the first country in Africa to abandon chloroquine for first-time therapy." | 7.69 | Parasitological and haematological responses to treatment of Plasmodium falciparum malaria with sulphadoxine-pyrimethamine in southern Malawi. ( Brabin, BJ; Kachale, B; Kazembe, P; Masache, P; Van der Kaay, HJ; Verhoeff, FH, 1997) |
| "Intermittent preventive treatment of malaria among schoolchildren (IPTsc) reduces clinical malaria, asymptomatic parasitemia, and anemia." | 7.11 | Overall and Gender-Specific Effects of Intermittent Preventive Treatment of Malaria with Artemisinin-Based Combination Therapies among Schoolchildren in Mali: A Three-Group Open Label Randomized Controlled Trial. ( Bamadio, A; Chico, RM; Cohee, LM; Coumare, S; Dara, A; Diarra, M; Djimde, AA; Doumbo, OK; Kodio, A; Maiga, H; Opondo, C; Sagara, I; Sidibe, B; Tekete, M; Traore, OB; Traore, ZI, 2022) |
| "Coverage of antenatal iron and folic acid (IFA) supplementation and malaria chemoprophylaxis remains low in many low-income and middle-income settings." | 5.69 | Improving coverage of antenatal iron and folic acid supplementation and malaria prophylaxis through targeted information and home deliveries in Côte d'Ivoire: a cluster randomised controlled trial. ( Dao, D; Fink, G; Koné, S; Probst-Hensch, N; Utzinger, J, 2023) |
| " There was significant association between gravidity and SP dosage taken (Pearson χ2 = 18." | 5.37 | The effectiveness and perception of the use of sulphadoxine-pyrimethamine in intermittent preventive treatment of malaria in pregnancy programme in Offinso district of Ashanti region, Ghana. ( Browne, E; Lawson, B; Tutu, EO, 2011) |
| "Intermittent preventive treatment of malaria in infants (IPTi) consists of the administration of a treatment dose of sulphadoxine-pyrimethamine (SP) at the time of routine vaccinations." | 5.15 | Evaluating the effectiveness of IPTi on malaria using routine health information from sentinel health centres in southern Tanzania. ( Alonso, P; Armstrong Schellenberg, JR; Chemba, M; Maokola, W; Mshinda, H; Schellenberg, D; Shirima, K; Tanner, M; Willey, BA, 2011) |
| "In 2003, Mali introduced intermittent preventive therapy in pregnancy (ITPp) with sulfadoxine-pyrimethamine (SP) for the control of malaria in pregnancy, consisting of 2 doses of SP given in the 2nd and 3rd trimester." | 5.15 | Superiority of 3 over 2 doses of intermittent preventive treatment with sulfadoxine-pyrimethamine for the prevention of malaria during pregnancy in mali: a randomized controlled trial. ( Bougoudogo, F; Coulibaly, S; Danis, M; Dara, A; Diakite, OS; Diallo, M; Djimde, A; Doumbo, OK; Doumbo, S; Doumtabé, D; Guindo, O; Karim, DM; Kayentao, K; Maiga, OM; Ongoiba, A; Ter Kuile, FO; Traoré, B; Traoré, BT; Traoré, M; Traoré, MS, 2011) |
| "During the 2003 and 2004 malaria transmission seasons, 1200 Gambian children with moderate or severe anaemia (Hb concentration <7 g/dL) were randomised to receive either monthly sulfadoxine-pyrimethamine (SP) or placebo until the end of the malaria transmission season in which they were enrolled, in a double-blind trial." | 5.14 | Prevention of the recurrence of anaemia in Gambian children following discharge from hospital. ( Abubakr, I; Bojang, KA; Conway, DJ; Greenwood, B; Jallow, M; Milligan, PJ; Njie, F; Nwakanma, DC; Sisay-Joof, F, 2010) |
| "Between March 2004 and March 2008, in an area of western Kenya with year round malaria transmission with high seasonal intensity and high usage of insecticide-treated nets, we conducted a randomized, double-blind placebo-controlled trial with SP plus 3 days of artesunate (SP-AS3), 3 days of amodiaquine-artesunate (AQ3-AS3), or 3 days of short-acting chlorproguanil-dapsone (CD3) administered at routine expanded programme of immunization visits (10 weeks, 14 weeks and 9 months)." | 5.14 | Intermittent preventive treatment in infants for the prevention of malaria in rural Western kenya: a randomized, double-blind placebo-controlled trial. ( Hamel, MJ; Kariuki, S; Lindblade, K; Newman, RD; Odhiambo, FO; Otieno, P; Peterson, E; Slutsker, L; ter Kuile, FO; Vulule, J; Williamson, J, 2010) |
| "In the context of a trial studying intermittent preventive sulfadoxine-pyrimethamine treatment of malaria in infants in Lambaréné, Gabon, children aged 18-30 months were followed up after having received their last dose at an age of 15 months." | 5.14 | No rebound of morbidity following intermittent preventive sulfadoxine-pyrimethamine treatment of malaria in infants in Gabon. ( Aponte, JJ; Borchert, LB; Doernemann, J; Gabor, JJ; Grobusch, MP; Issifou, S; Koester, KB; Kremsner, PG; Kurth, F; Lell, B; Poetschke, M; Pongratz, P; Profanter, K; Schuster, K; Schwarz, NG, 2009) |
| "The use of sulfadoxine-pyrimethamine (SP) for intermittent preventive treatment in pregnancy (IPTp) is threatened by the spread of resistance to SP." | 5.13 | A randomized, controlled trial of intermittent preventive treatment with sulfadoxine-pyrimethamine, amodiaquine, or the combination in pregnant women in Ghana. ( Affipunguh, PK; Bruce, J; Chandramohan, D; Clerk, CA; Greenwood, B; Hodgson, A; Mensah, N, 2008) |
| "Monthly artesunate plus amodiaquine reduced the incidence of malaria by 69% (95% CI: 63%, 74%) and anaemia by 45% (95% CI: 25%,60%), bimonthly sulphadoxine-pyrimethamine reduced the incidence of malaria by 24% (95% CI: 14%,33%) and anaemia by 30% (95% CI: 6%, 49%) and bimonthly artesunate plus amodiaquine reduced the incidence of malaria by 17% (95% CI: 6%, 27%) and anaemia by 32% (95% CI: 7%, 50%) compared to placebo." | 5.13 | Seasonal intermittent preventive treatment for the prevention of anaemia and malaria in Ghanaian children: a randomized, placebo controlled trial. ( Adjuik, M; Binka, F; Chandramohan, D; Greenwood, B; Kweku, M; Liu, D; Seidu, M, 2008) |
| "The main objective of the study was to assess the impact of a community-based delivery system of intermittent preventive treatment (IPT) for malaria in pregnancy with sulfadoxine-pyrimethamine (SP) on access, parasitemia, anemia and low birth weight as primary outcome measures." | 5.13 | Intermittent preventive treatment of malaria in pregnancy: a community-based delivery system and its effect on parasitemia, anemia and low birth weight in Uganda. ( Bygbjerg, I; Magnussen, P; Mbonye, AK, 2008) |
| "Intermittent preventive treatment with three doses of sulfadoxine-pyrimethamine is a more effective strategy to prevent maternal anemia during pregnancy in Burkina Faso." | 5.13 | [Comparative impact of three malaria preventive regimens during pregnancy on maternal anemia due to malaria in Burkina Faso]. ( Bougouma, EC; Diarra, A; Konaté, AT; Nébié, I; Ouédraogo, A; Sirima, SB; Tiono, AB, 2008) |
| "The study design was an open randomized control trial comparing anaemia incidence among pregnant women on intermittent presumptive treatment of malaria with SP with those on chloroquine (CQ)." | 5.13 | Efficacy of intermittent preventive treatment of malaria with sulphadoxine-pyrimethamine in preventing anaemia in pregnancy among Nigerian women. ( Abiona, TC; Asa, OO; Fatusi, AO; Ijadunola, KT; Onayade, AA, 2008) |
| "Whether administration of folic acid to children with malaria anemia is helpful is controversial." | 5.12 | Folic acid treatment of Zambian children with moderate to severe malaria anemia. ( Bennett, S; Fielding, K; Greenwood, B; Malunga, P; Mulenga, M; Shulman, C; Thuma, P, 2006) |
| " We tested the hypothesis that artesunate-sulfamethoxypyrazine-pyrimethamine is as efficacious as the four-dose regimen of artemether-lumefantrine for treatment of Plasmodium falciparum malaria." | 5.12 | A randomized trial of artesunate-sulfamethoxypyrazine-pyrimethamine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali. ( Dicko, A; Djimde, A; Doumbo, OK; Fofana, M; Guindo, O; Jansen, HF; Kone, M; Ouattara, A; Sagara, I; Sissoko, M; Sogoba, M; Thera, MA; Tolo, Y, 2006) |
| " The purpose was to compare the efficacy of two regimens using chloroquine (CQ) or sulfadoxine-pyrimethamine (SP) during pregnancy and delivery in a village located in an endemic area of Mali." | 5.12 | [Randomized clinical trial of two malaria prophylaxis regimens for pregnant women in Faladie, Mali]. ( Dabo, CA; Diallo, M; Diarra, MA; Doumbo, O; Kayentao, K; Ongoiba, A; Sangho, H; Saye, R; Yattara, O, 2007) |
| "The World Health Organization advocates 2-3 doses of sulfadoxine-pyrimethamine (SP) for intermittent preventive treatment of malaria (SP IPTp)." | 5.12 | Inferiority of single-dose sulfadoxine-pyrimethamine intermittent preventive therapy for malaria during pregnancy among HIV-positive Zambian women. ( Chalwe, V; Champo, D; Chilengi, R; Gill, CJ; Hamer, DH; Macleod, WB; Mukwamataba, D; Mwanakasale, V; Mwananyanda, L; Thea, DM, 2007) |
| "We investigated the ability of intermittent preventive treatment in pregnancy (IPTp) with sulphadoxine/pyrimethamine to prevent anaemia and low birthweight in Gambian multigravidae." | 5.12 | A randomized, placebo-controlled trial of intermittent preventive treatment with sulphadoxine-pyrimethamine in Gambian multigravidae. ( Balajo, B; Dunyo, S; Greenwood, B; Mbaye, A; Milligan, P; Richardson, K; Shulman, C; Walraven, G, 2006) |
| "Intermittent preventive treatment for malaria with sulfadoxine-pyrimethamine can reduce malaria and anaemia in infants even in seasonal, high transmission areas, but concern exists about possible rebound in the incidence of malaria in the second year of life." | 5.11 | Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana. ( Amponsa-Achiano, K; Awine, T; Baiden, R; Binka, F; Carneiro, I; Chandramohan, D; Greenwood, B; Hodgson, A; Jaffar, S; Mensah, N; Owusu-Agyei, S, 2005) |
| "In Mali, IPT with SP appears more efficacious than weekly chloroquine chemoprophylaxis in preventing malaria during pregnancy." | 5.11 | Comparison of intermittent preventive treatment with chemoprophylaxis for the prevention of malaria during pregnancy in Mali. ( Coulibaly, D; Doumbo, O; Doumtabe, D; Kayentao, K; Keita, AS; Kodio, M; Maiga, B; Maiga, H; Mungai, M; Newman, RD; Ongoiba, A; Parise, ME, 2005) |
| "The World Health Organization recommends intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine-pyrimethamine for malaria for all women who live in moderate to high malaria transmission areas in Africa." | 4.98 | Mefloquine for preventing malaria in pregnant women. ( Aponte, JJ; González, R; Menéndez, C; Piqueras, M; Pons-Duran, C; Ter Kuile, FO, 2018) |
| "In 2012, WHO changed its recommendation for intermittent preventive treatment of malaria during pregnancy (IPTp) from two doses to monthly doses of sulfadoxine-pyrimethamine during the second and third trimesters, but noted the importance of a cost-effectiveness analysis to lend support to the decision of policy makers." | 4.91 | Cost-effectiveness of two versus three or more doses of intermittent preventive treatment for malaria during pregnancy in sub-Saharan Africa: a modelling study of meta-analysis and cost data. ( Akazili, J; Fernandes, S; Hanson, K; Hill, J; Kayentao, K; Madanitsa, M; Sicuri, E; ter Kuile, FO; van Eijk, AM; Webster, J; Were, V, 2015) |
| "In 2012 the World Health Organisation (WHO) revised the policy on Intermittent Preventive Treatment with Sulphadoxine Pyrimethamine (IPTp-SP) to at least three doses for improved protection against malaria parasitaemia and its associated effects such as anaemia during pregnancy." | 4.02 | Intermittent preventive treatment comparing two versus three doses of sulphadoxine pyrimethamine (IPTp-SP) in the prevention of anaemia in pregnancy in Ghana: A cross-sectional study. ( Agyeman, YN; Annor, RB; Newton, S; Owusu-Dabo, E, 2021) |
| " Structured interview and antenatal clinic cards were used to obtain data including the use of intermittent preventive therapy in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP)." | 3.91 | Adverse birth outcomes among mothers who received intermittent preventive treatment with Sulphadoxine-Pyrimethamine in the low malaria transmission region. ( Aklillu, E; Kamuhabwa, AAR; Mikomangwa, WP; Oms, M, 2019) |
| "To investigate whether high-dosed folate supplements might diminish the efficacy of malaria intermittent preventive treatment in pregnancy (IPTp) with sulphadoxine-pyrimethamine (SP) in a cohort of pregnant women in Benin, where malaria is holoendemic." | 3.88 | High folate levels are not associated with increased malaria risk but with reduced anaemia rates in the context of high-dosed folate supplements and intermittent preventive treatment against malaria in pregnancy with sulphadoxine-pyrimethamine in Benin. ( Accrombessi, M; Cot, M; Moya-Alvarez, V; Ouédraogo, S, 2018) |
| "The impact of sulfadoxine-pyrimethamine (SP) used as intermittent preventive treatment during pregnancy (IPTp-SP) on mutant parasite selection has been poorly documented in Burkina Faso." | 3.85 | Recent uptake of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine is associated with increased prevalence of Pfdhfr mutations in Bobo-Dioulasso, Burkina Faso. ( Awandare, GA; Cisse, M; Guiguemdé, RT; Hayette, MP; Soulama, A; Tinto, H, 2017) |
| "Six years after the implementation of intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine-pyrimethamine (SP) in Gabon, its impact on placental malaria and pregnancy outcomes remains unknown." | 3.83 | Decrease of microscopic Plasmodium falciparum infection prevalence during pregnancy following IPTp-SP implementation in urban cities of Gabon. ( Ambounda, N; Bouyou-Akotet, MK; Kendjo, E; Kombila, M; Mawili-Mboumba, DP; Moutandou Chiesa, S; Tshibola Mbuyi, ML; Tsoumbou-Bakana, G; Zong, J, 2016) |
| "The effectiveness of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine (IPTp-SP) against malaria and anemia is unclear because of the spread of SP-resistant Plasmodium falciparum." | 3.77 | Intermittent preventive treatment with sulfadoxine-pyrimethamine against malaria and anemia in pregnant women. ( Adjei, AA; Anderson, WA; Ceesay, FK; Gyasi, RK; Lucchi, NW; Ndjakani, Y; Obed, SA; Rodney, P; Stiles, JK; Wilson, NO, 2011) |
| "To assess the effect of intermittent preventive treatment with sulfadoxine and pyrimethamine (IPT-SP) on placental parasitemia and maternal and perinatal outcome." | 3.77 | Efficacy of intermittent preventive treatment with sulfadoxine-pyrimethamine on placental parasitemia in pregnant women in midwestern Nigeria. ( Akubuo, KK; Aziken, ME; Gharoro, EP, 2011) |
| "Effectiveness of cotrimoxazole (CTX) compared with sulfadoxine-pyrimethamine (SP) intermittent-preventive-therapy (IPTp) for malaria in HIV-infected pregnant women is unknown." | 3.77 | Marked reduction in prevalence of malaria parasitemia and anemia in HIV-infected pregnant women taking cotrimoxazole with or without sulfadoxine-pyrimethamine intermittent preventive therapy during pregnancy in Malawi. ( Fitzgerald, M; Kapito-Tembo, A; Meshnick, SR; Mwapasa, V; Phiri, K; van Hensbroek, MB, 2011) |
| "Data on antenatal attendance, uptake of intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP), birthweight, malaria, anaemia, for 2,152 primigravidae." | 3.76 | Trends in pregnancy outcomes in Malawian adolescents receiving antimalarial and hematinic supplements. ( Brabin, BJ; D'Alessandro, U; Gies, S; Kalanda, G; Kazembe, P; Msyamboza, K; Savage, E, 2010) |
| "To evaluate the impact of a 2-year programme for community-based delivery of sulfadoxine-pyrimethamine (SP) on intermittent preventive treatment during pregnancy coverage, antenatal clinic attendance and pregnancy outcome." | 3.75 | Community-based distribution of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy improved coverage but reduced antenatal attendance in southern Malawi. ( Brabin, BJ; D'Alessandro, U; Gies, S; Kalanda, G; Kazembe, PN; Msyamboza, KP; Savage, EJ, 2009) |
| "To appraise the prevalence of malaria and anaemia in antenatal mothers; and explore the factors influencing coverage of intermittent preventive treatment (IPT) with sulfadoxine-pyrimethamine (SP) under operational conditions in the national programme for malaria control in pregnancy." | 3.74 | Appraisal on the prevalence of malaria and anaemia in pregnancy and factors influencing uptake of intermittent preventive therapy with sulfadoxine-pyrimethamine in Kibaha district, Tanzania. ( Tarimo, SD, 2007) |
| "Intermittent preventive treatment in pregnancy with sulphadoxine-pyrimethamine (IPTp-SP) has been adopted as policy by many countries in sub-Saharan Africa." | 3.74 | Decline of placental malaria in southern Ghana after the implementation of intermittent preventive treatment in pregnancy. ( Acquah, PA; Bedu-Addo, G; Bienzle, U; Eggelte, TA; Holmberg, V; Hommerich, L; Mockenhaupt, FP; von Oertzen, C, 2007) |
| "Anaemia [haemoglobin (Hb) <11 g/dl), severe anaemia (Hb <8 g/dl) and placental malaria were compared among women with known HIV status who delivered at a provincial hospital after study enrolment in the third trimester during three consecutive periods: period 1, no routine intervention (reference); period 2, routine haematinic supplementation (60 mg elementary iron three times/day, folic acid 5 mg once daily) and period 3, haematinics and IPT with SP." | 3.74 | Effect of haematinic supplementation and malaria prevention on maternal anaemia and malaria in western Kenya. ( Ayisi, JG; Kager, PA; Nahlen, BL; Otieno, JA; Rosen, DH; Shi, YP; Slutsker, L; Steketee, RW; Ter Kuile, FO; van Eijk, AM, 2007) |
| "Febrile adults with Plasmodium falciparum parasitemia were treated with sulfadoxine-pyrimethamine and were monitored for 28 days." | 3.73 | HIV immunosuppression and antimalarial efficacy: sulfadoxine-pyrimethamine for the treatment of uncomplicated malaria in HIV-infected adults in Siaya, Kenya. ( Bloland, PB; Hamel, MJ; Kain, KC; Obonyo, CO; Shah, SN; Slutsker, L; Smith, EE, 2006) |
| "To reduce the intolerable burden of malaria in pregnancy, the Ministry of Health in Tanzania has recently adopted a policy of intermittent presumptive treatment for pregnant women using sulphadoxine-pyrimethamine (IPTp-SP)." | 3.72 | Knowledge of malaria influences the use of insecticide treated nets but not intermittent presumptive treatment by pregnant women in Tanzania. ( Drakeley, C; Marchant, T; Nganda, RY; Reyburn, H, 2004) |
| "The study population consisted of 26 Zambian children < 6 years of age who presented with cerebral malaria to a rural hospital in 1994 and who were treated with quinine for seven days." | 3.70 | Prolonged macrophage activation and persistent anaemia in children with complicated malaria. ( Biemba, G; Gordeuk, VR; Mabeza, GF; Thuma, PE; Weiss, G, 1998) |
| "In 1993, Malawi introduced sulphadoxine-pyrimethamine (SP) for the treatment of uncomplicated, Plasmodium falciparum malaria and became the first country in Africa to abandon chloroquine for first-time therapy." | 3.69 | Parasitological and haematological responses to treatment of Plasmodium falciparum malaria with sulphadoxine-pyrimethamine in southern Malawi. ( Brabin, BJ; Kachale, B; Kazembe, P; Masache, P; Van der Kaay, HJ; Verhoeff, FH, 1997) |
| "Intermittent preventive treatment of malaria among schoolchildren (IPTsc) reduces clinical malaria, asymptomatic parasitemia, and anemia." | 3.11 | Overall and Gender-Specific Effects of Intermittent Preventive Treatment of Malaria with Artemisinin-Based Combination Therapies among Schoolchildren in Mali: A Three-Group Open Label Randomized Controlled Trial. ( Bamadio, A; Chico, RM; Cohee, LM; Coumare, S; Dara, A; Diarra, M; Djimde, AA; Doumbo, OK; Kodio, A; Maiga, H; Opondo, C; Sagara, I; Sidibe, B; Tekete, M; Traore, OB; Traore, ZI, 2022) |
| "In endemic areas, malaria and its adverse effects in schoolchildren may be prevented by intermittent preventive treatment (IPTsc)." | 2.84 | Efficacy and safety of intermittent preventive treatment in schoolchildren with sulfadoxine/pyrimethamine (SP) and SP plus piperaquine in Democratic Republic of the Congo: a randomised controlled trial. ( da Luz, RI; Doua, JY; Lutumba, P; Matangila, JR; Mitashi, P; Van Geertruyden, JP, 2017) |
| "Asymptomatic falciparum malaria is associated with poorer cognitive performance in African schoolchildren and intermittent preventive treatment of malaria improves cognitive outcomes." | 2.82 | Malaria illness mediated by anaemia lessens cognitive development in younger Ugandan children. ( Bass, JK; Bigira, V; Boivin, MJ; Dorsey, G; Familiar-Lopez, I; Kamya, M; Kapisi, J; Muhindo, M; Nakasujja, N; Opoka, RO; Ruiseñor-Escudero, H; Sikorskii, A, 2016) |
| " CF fortified with highly bioavailable iron improved iron status but not Hb concentration, despite three-monthly IPT of malaria." | 2.80 | The effect of iron-fortified complementary food and intermittent preventive treatment of malaria on anaemia in 12- to 36-month-old children: a cluster-randomised controlled trial. ( Adiossan, LG; Brittenham, GM; Diakité, VG; Glinz, D; Hurrell, RF; N'Goran, EK; Ouattara, M; Righetti, AA; Seifert, B; Utzinger, J; Wegmüller, R; Zimmermann, MB, 2015) |
| "Intermittent preventive treatment for malaria in children (IPTc) involves the administration of a full course of an anti-malarial treatment to children under 5 years old at specified time points regardless of whether or not they are known to be infected, in areas where malaria transmission is seasonal." | 2.75 | Cost effectiveness of seasonal intermittent preventive treatment using amodiaquine & artesunate or sulphadoxine-pyrimethamine in Ghanaian children. ( Chandramohan, D; Conteh, L; Greenwood, B; Kweku, M; Legood, R; Patouillard, E, 2010) |
| " However, the optimal dosing regimen in settings in which human immunodeficiency virus (HIV) is highly prevalent among pregnant women remains controversial." | 2.73 | Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-seropositive pregnant Zambian women. ( Chalwe, V; Champo, D; Chilengi, R; Gill, CJ; Hamer, DH; Macleod, WB; Mubikayi, L; Mukwamataba, D; Mulele, CK; Mulenga, M; Mwanakasale, V; Mwananyanda, L; Thea, DM, 2007) |
| "Malaria was an important risk factor for any and moderate anaemia; use of an insecticide-treated net (ITN) was a protective factor for any anaemia." | 2.73 | Malaria and anaemia among pregnant women at first antenatal clinic visit in Kisumu, western Kenya. ( Ayisi, JG; Hamel, MJ; Kager, PA; Otieno, K; Ouma, P; Parise, M; Slutsker, L; van Eijk, AM, 2007) |
| "Intermittent preventive treatment for malaria in Infants (IPTi) has been shown to give effective and safe protection against malaria." | 2.73 | Duration of protection against malaria and anaemia provided by intermittent preventive treatment in infants in Navrongo, Ghana. ( Awine, T; Cairns, M; Carneiro, I; Chandramohan, D; Gosling, R; Greenwood, B; Milligan, P; Owusu-Agyei, S, 2008) |
| "Malaria in pregnancy is a significant contributor to adverse pregnancy outcome, especially in Sub-Saharan Africa." | 2.49 | A systematic review of the impact of malaria prevention in pregnancy on low birth weight and maternal anemia. ( Dent, AE; Goldenberg, RL; McClure, EM; Meshnick, SR, 2013) |
| "IPTi with sulfadoxine-pyrimethamine was safe and efficacious across a range of malaria transmission settings, suggesting that this intervention is a useful contribution to malaria control." | 2.45 | Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials. ( Adjei, S; Alonso, P; Anemana, S; Aponte, JJ; Breckenridge, A; Carneiro, I; Chandramohan, D; Critchley, J; Danquah, I; Dodoo, A; Egan, A; Greenwood, B; Grobusch, MP; Issifou, S; Kobbe, R; Kremsner, PG; Lell, B; Macete, E; May, J; Menendez, C; Mockenhaupt, F; Mshinda, H; Newman, RD; Owusu-Agyei, S; Premji, Z; Sanz, S; Schellenberg, D; Sevene, E; Slutsker, L; Soulaymani-Becheikh, R; Tanner, M; Winstanley, P, 2009) |
| "Severe anaemia in pregnancy is an important contributor to maternal and perinatal morbidity and mortality." | 2.40 | Malaria in pregnancy: its relevance to safe-motherhood programmes. ( Shulman, CE, 1999) |
| "Malaria in pregnancy is an immense public health problem with at least 50 million pregnant women living in malaria endemic areas." | 1.43 | Assessment of the usage and effectiveness of intermittent preventive treatment and insecticide-treated nets on the indicators of malaria among pregnant women attending antenatal care in the Buea Health District, Cameroon. ( Anchang-Kimbi, JK; Fokam, EB; Ngimuh, L; Wanji, S, 2016) |
| " There was significant association between gravidity and SP dosage taken (Pearson χ2 = 18." | 1.37 | The effectiveness and perception of the use of sulphadoxine-pyrimethamine in intermittent preventive treatment of malaria in pregnancy programme in Offinso district of Ashanti region, Ghana. ( Browne, E; Lawson, B; Tutu, EO, 2011) |
| "Severe malaria has been neglected as a subject for clinical investigation, and there is little information available on which to base rational treatment." | 1.27 | Management of Plasmodium falciparum malaria. ( Phillips, RE, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (14.88) | 18.7374 |
| 1990's | 5 (4.13) | 18.2507 |
| 2000's | 50 (41.32) | 29.6817 |
| 2010's | 40 (33.06) | 24.3611 |
| 2020's | 8 (6.61) | 2.80 |
| Authors | Studies |
|---|---|
| Woodruff, AW | 1 |
| Ahadzie-Soglie, A | 1 |
| Addai-Mensah, O | 1 |
| Abaka-Yawson, A | 1 |
| Setroame, AM | 1 |
| Kwadzokpui, PK | 1 |
| Maiga, H | 3 |
| Opondo, C | 1 |
| Chico, RM | 1 |
| Cohee, LM | 1 |
| Sagara, I | 2 |
| Traore, OB | 2 |
| Tekete, M | 2 |
| Dara, A | 4 |
| Traore, ZI | 2 |
| Diarra, M | 1 |
| Coumare, S | 1 |
| Kodio, A | 1 |
| Bamadio, A | 1 |
| Sidibe, B | 1 |
| Doumbo, OK | 6 |
| Djimde, AA | 2 |
| Ampofo, GD | 1 |
| Osarfo, J | 1 |
| Aberese-Ako, M | 1 |
| Asem, L | 1 |
| Komey, MN | 1 |
| Mohammed, W | 1 |
| Ofosu, AA | 1 |
| Tagbor, H | 1 |
| Crider, K | 1 |
| Williams, J | 1 |
| Qi, YP | 1 |
| Gutman, J | 1 |
| Yeung, L | 1 |
| Mai, C | 1 |
| Finkelstain, J | 1 |
| Mehta, S | 1 |
| Pons-Duran, C | 2 |
| Menéndez, C | 5 |
| Moraleda, C | 1 |
| Rogers, L | 1 |
| Daniels, K | 1 |
| Green, P | 1 |
| Uwimana, A | 1 |
| Sethi, R | 1 |
| Murindahabi, M | 1 |
| Ntirandeka, C | 1 |
| Piercefield, E | 1 |
| Umulisa, N | 1 |
| Abram, A | 1 |
| Eckert, E | 1 |
| Munguti, K | 1 |
| Sullivan, D | 1 |
| Uyizeye, D | 1 |
| Mbituyumuremyi, A | 1 |
| Gutman, JR | 1 |
| Koné, S | 1 |
| Probst-Hensch, N | 1 |
| Dao, D | 1 |
| Utzinger, J | 2 |
| Fink, G | 1 |
| Anabire, NG | 1 |
| Aculley, B | 1 |
| Pobee, A | 1 |
| Kyei-Baafour, E | 1 |
| Awandare, GA | 2 |
| Del Pilar Quintana, M | 1 |
| Hviid, L | 1 |
| Ofori, MF | 1 |
| Unger, HW | 1 |
| Rosanas-Urgell, A | 1 |
| Robinson, LJ | 1 |
| Ome-Kaius, M | 1 |
| Jally, S | 1 |
| Umbers, AJ | 1 |
| Pomat, W | 1 |
| Mueller, I | 1 |
| Kattenberg, E | 1 |
| Rogerson, SJ | 1 |
| Agyeman, YN | 1 |
| Newton, S | 1 |
| Annor, RB | 1 |
| Owusu-Dabo, E | 1 |
| Moya-Alvarez, V | 1 |
| Ouédraogo, S | 1 |
| Accrombessi, M | 1 |
| Cot, M | 2 |
| González, R | 1 |
| Piqueras, M | 1 |
| Aponte, JJ | 4 |
| Ter Kuile, FO | 9 |
| Mikomangwa, WP | 1 |
| Oms, M | 1 |
| Aklillu, E | 1 |
| Kamuhabwa, AAR | 1 |
| McClure, EM | 1 |
| Goldenberg, RL | 1 |
| Dent, AE | 1 |
| Meshnick, SR | 3 |
| Doumbo, S | 2 |
| Ongoiba, OA | 1 |
| Doumtabé, D | 3 |
| Ouologuem, TD | 1 |
| Kayentao, K | 5 |
| Djimdé, A | 3 |
| Traoré, B | 2 |
| Aguilar, R | 1 |
| Marrocco, T | 1 |
| Skorokhod, OA | 1 |
| Barbosa, A | 1 |
| Nhabomba, A | 1 |
| Manaca, MN | 1 |
| Guinovart, C | 1 |
| Quintó, L | 1 |
| Arese, P | 1 |
| Alonso, PL | 2 |
| Dobaño, C | 1 |
| Schwarzer, E | 1 |
| Valea, I | 2 |
| Tinto, H | 4 |
| Drabo, MK | 2 |
| Huybregts, L | 2 |
| Henry, MC | 1 |
| Roberfroid, D | 1 |
| Guiguemde, RT | 4 |
| Kolsteren, P | 2 |
| D'Alessandro, U | 7 |
| Mosha, D | 1 |
| Chilongola, J | 1 |
| Ndeserua, R | 1 |
| Mwingira, F | 1 |
| Genton, B | 1 |
| Cisse, M | 2 |
| Sangare, I | 1 |
| Lougue, G | 1 |
| Bamba, S | 1 |
| Bayane, D | 1 |
| Fernandes, S | 1 |
| Sicuri, E | 1 |
| van Eijk, AM | 4 |
| Hill, J | 1 |
| Webster, J | 1 |
| Were, V | 1 |
| Akazili, J | 1 |
| Madanitsa, M | 1 |
| Hanson, K | 1 |
| Briand, V | 1 |
| Escolano, S | 1 |
| Journot, V | 1 |
| Massougbodji, A | 2 |
| Tubert-Bitter, P | 1 |
| Glinz, D | 1 |
| Hurrell, RF | 1 |
| Ouattara, M | 1 |
| Zimmermann, MB | 1 |
| Brittenham, GM | 1 |
| Adiossan, LG | 1 |
| Righetti, AA | 1 |
| Seifert, B | 1 |
| Diakité, VG | 1 |
| N'Goran, EK | 1 |
| Wegmüller, R | 1 |
| Fokam, EB | 1 |
| Ngimuh, L | 1 |
| Anchang-Kimbi, JK | 1 |
| Wanji, S | 1 |
| Boivin, MJ | 1 |
| Sikorskii, A | 1 |
| Familiar-Lopez, I | 1 |
| Ruiseñor-Escudero, H | 1 |
| Muhindo, M | 1 |
| Kapisi, J | 1 |
| Bigira, V | 1 |
| Bass, JK | 1 |
| Opoka, RO | 1 |
| Nakasujja, N | 1 |
| Kamya, M | 1 |
| Dorsey, G | 1 |
| Bouyou-Akotet, MK | 2 |
| Mawili-Mboumba, DP | 1 |
| Kendjo, E | 2 |
| Moutandou Chiesa, S | 1 |
| Tshibola Mbuyi, ML | 1 |
| Tsoumbou-Bakana, G | 1 |
| Zong, J | 1 |
| Ambounda, N | 1 |
| Kombila, M | 2 |
| Matangila, JR | 1 |
| Doua, JY | 1 |
| Mitashi, P | 1 |
| da Luz, RI | 1 |
| Lutumba, P | 1 |
| Van Geertruyden, JP | 2 |
| Soulama, A | 1 |
| Hayette, MP | 1 |
| Mbonye, AK | 2 |
| Hansen, KS | 1 |
| Bygbjerg, IC | 2 |
| Magnussen, P | 3 |
| Clarke, SE | 2 |
| Jukes, MC | 2 |
| Njagi, JK | 2 |
| Khasakhala, L | 1 |
| Cundill, B | 1 |
| Otido, J | 1 |
| Crudder, C | 1 |
| Estambale, BB | 2 |
| Brooker, S | 2 |
| Naniche, D | 1 |
| Lahuerta, M | 1 |
| Bardaji, A | 1 |
| Sigauque, B | 1 |
| Romagosa, C | 1 |
| Berenguera, A | 1 |
| Mandomando, I | 1 |
| David, C | 1 |
| Sanz, S | 2 |
| Aponte, J | 1 |
| Ordi, J | 1 |
| Alonso, P | 4 |
| Clerk, CA | 1 |
| Bruce, J | 1 |
| Affipunguh, PK | 1 |
| Mensah, N | 2 |
| Hodgson, A | 3 |
| Greenwood, B | 11 |
| Chandramohan, D | 8 |
| Manzi, F | 1 |
| Schellenberg, J | 1 |
| Hamis, Y | 1 |
| Mushi, AK | 1 |
| Shirima, K | 2 |
| Mwita, A | 1 |
| Simba, A | 1 |
| Rusibamayila, N | 1 |
| Kitambi, M | 1 |
| Tanner, M | 4 |
| Mshinda, H | 4 |
| Schellenberg, D | 4 |
| Temperley, M | 1 |
| Mueller, DH | 1 |
| Akhwale, W | 1 |
| Kweku, M | 2 |
| Liu, D | 1 |
| Adjuik, M | 2 |
| Binka, F | 2 |
| Seidu, M | 1 |
| Billal, DS | 1 |
| Hotomi, M | 1 |
| Yamanaka, N | 1 |
| Gies, S | 3 |
| Coulibaly, SO | 2 |
| Ouattara, FT | 1 |
| Msyamboza, KP | 1 |
| Savage, EJ | 1 |
| Kazembe, PN | 1 |
| Kalanda, G | 2 |
| Brabin, BJ | 3 |
| Barger, B | 1 |
| Tembine, I | 2 |
| Gantt, S | 1 |
| Egan, A | 1 |
| Breckenridge, A | 1 |
| Carneiro, I | 3 |
| Critchley, J | 1 |
| Danquah, I | 2 |
| Dodoo, A | 1 |
| Kobbe, R | 1 |
| Lell, B | 3 |
| May, J | 1 |
| Premji, Z | 1 |
| Sevene, E | 1 |
| Soulaymani-Becheikh, R | 1 |
| Winstanley, P | 1 |
| Adjei, S | 1 |
| Anemana, S | 1 |
| Issifou, S | 3 |
| Mockenhaupt, F | 1 |
| Owusu-Agyei, S | 3 |
| Grobusch, MP | 3 |
| Kremsner, PG | 3 |
| Macete, E | 1 |
| Newman, RD | 3 |
| Slutsker, L | 5 |
| Gabor, JJ | 1 |
| Schwarz, NG | 2 |
| Poetschke, M | 1 |
| Doernemann, J | 1 |
| Schuster, K | 1 |
| Koester, KB | 1 |
| Profanter, K | 1 |
| Borchert, LB | 1 |
| Kurth, F | 1 |
| Pongratz, P | 2 |
| Nzenze-Afene, S | 1 |
| Ngoungou, EB | 1 |
| Owono-Medang, M | 1 |
| Lekana-Douki, JB | 1 |
| Obono-Obiang, G | 1 |
| Mounanga, M | 1 |
| Shekalaghe, SA | 1 |
| ter Braak, R | 1 |
| Daou, M | 1 |
| Kavishe, R | 1 |
| van den Bijllaardt, W | 1 |
| van den Bosch, S | 1 |
| Koenderink, JB | 1 |
| Luty, AJ | 1 |
| Whitty, CJ | 1 |
| Drakeley, C | 2 |
| Sauerwein, RW | 1 |
| Bousema, T | 1 |
| Odhiambo, FO | 1 |
| Hamel, MJ | 3 |
| Williamson, J | 1 |
| Lindblade, K | 1 |
| Peterson, E | 1 |
| Otieno, P | 1 |
| Kariuki, S | 1 |
| Vulule, J | 1 |
| Msyamboza, K | 1 |
| Savage, E | 1 |
| Kazembe, P | 2 |
| Bojang, KA | 1 |
| Milligan, PJ | 3 |
| Conway, DJ | 1 |
| Sisay-Joof, F | 1 |
| Jallow, M | 1 |
| Nwakanma, DC | 1 |
| Abubakr, I | 1 |
| Njie, F | 1 |
| Oduro, AR | 1 |
| Fryauff, DJ | 1 |
| Koram, KA | 1 |
| Rogers, WO | 1 |
| Anto, F | 1 |
| Atuguba, F | 1 |
| Anyorigiya, T | 1 |
| Ansah, P | 1 |
| Nkrumah, F | 1 |
| Conteh, L | 1 |
| Patouillard, E | 1 |
| Legood, R | 1 |
| Gara, SN | 1 |
| Madaki, AJ | 1 |
| Thacher, TD | 1 |
| Aziken, ME | 1 |
| Akubuo, KK | 1 |
| Gharoro, EP | 1 |
| Kapito-Tembo, A | 1 |
| van Hensbroek, MB | 1 |
| Phiri, K | 1 |
| Fitzgerald, M | 1 |
| Mwapasa, V | 1 |
| Willey, BA | 1 |
| Armstrong Schellenberg, JR | 1 |
| Maokola, W | 1 |
| Chemba, M | 1 |
| Maiga, AS | 1 |
| Diakite, M | 1 |
| Diawara, A | 1 |
| Sango, HA | 1 |
| Coulibaly, CO | 1 |
| Wilson, NO | 1 |
| Ceesay, FK | 1 |
| Obed, SA | 1 |
| Adjei, AA | 1 |
| Gyasi, RK | 1 |
| Rodney, P | 1 |
| Ndjakani, Y | 1 |
| Anderson, WA | 1 |
| Lucchi, NW | 1 |
| Stiles, JK | 1 |
| Diakite, OS | 1 |
| Maiga, OM | 1 |
| Traoré, BT | 1 |
| Diallo, M | 2 |
| Traoré, M | 2 |
| Ongoiba, A | 3 |
| Traoré, MS | 1 |
| Guindo, O | 2 |
| Karim, DM | 1 |
| Coulibaly, S | 1 |
| Bougoudogo, F | 1 |
| Danis, M | 1 |
| Konaté, AT | 2 |
| Yaro, JB | 1 |
| Ouédraogo, AZ | 1 |
| Diarra, A | 2 |
| Gansané, A | 1 |
| Soulama, I | 1 |
| Kangoyé, DT | 1 |
| Kaboré, Y | 1 |
| Ouédraogo, E | 1 |
| Ouédraogo, A | 2 |
| Tiono, AB | 2 |
| Ouédraogo, IN | 1 |
| Cousens, S | 2 |
| Sirima, SB | 2 |
| Greenwood, BM | 2 |
| Diallo, DA | 2 |
| Dicko, A | 2 |
| Barry, A | 1 |
| Dicko, M | 1 |
| Diallo, AI | 1 |
| Dicko, Y | 1 |
| Dara, N | 1 |
| Sidibe, Y | 1 |
| Santara, G | 1 |
| Conaré, T | 1 |
| Taylor, SM | 1 |
| Hand, CC | 1 |
| Mwandagalirwa, K | 1 |
| Messina, JP | 1 |
| Tshefu, AK | 1 |
| Atua, B | 1 |
| Emch, M | 1 |
| Muwonga, J | 1 |
| Tine, RC | 1 |
| Faye, B | 1 |
| Ndour, CT | 1 |
| Ndiaye, JL | 1 |
| Ndiaye, M | 1 |
| Bassene, C | 1 |
| Sylla, K | 1 |
| Ndour, JD | 1 |
| Gaye, O | 1 |
| Tutu, EO | 1 |
| Lawson, B | 1 |
| Browne, E | 1 |
| Sorgho, H | 1 |
| Ouedraogo, JB | 2 |
| Shaukat, AM | 1 |
| Gilliams, EA | 1 |
| Kenefic, LJ | 1 |
| Laurens, MB | 1 |
| Dzinjalamala, FK | 2 |
| Nyirenda, OM | 1 |
| Thesing, PC | 1 |
| Jacob, CG | 1 |
| Molyneux, ME | 2 |
| Taylor, TE | 2 |
| Plowe, CV | 2 |
| Laufer, MK | 1 |
| Urassa, DP | 1 |
| Nystrom, L | 1 |
| Carlsted, A | 1 |
| Verhoef, H | 2 |
| West, CE | 2 |
| Nzyuko, SM | 1 |
| de Vogel, S | 1 |
| van der Valk, R | 1 |
| Wanga, MA | 1 |
| Kuijsten, A | 1 |
| Veenemans, J | 1 |
| Kok, FJ | 1 |
| Zoungrana, EB | 1 |
| Guiguemde, TR | 1 |
| Van Marck, E | 1 |
| Desai, MR | 3 |
| Mei, JV | 1 |
| Kariuki, SK | 3 |
| Wannemuehler, KA | 2 |
| Phillips-Howard, PA | 1 |
| Nahlen, BL | 2 |
| Kager, PA | 5 |
| Vulule, JM | 1 |
| MARCHAL, G | 1 |
| BILSKI-PASQUIER, G | 1 |
| CAP, J | 1 |
| BOCK, HE | 1 |
| FREY, J | 1 |
| SCHUBERT, JC | 1 |
| SCHUBERT, H | 1 |
| MARTIN, H | 1 |
| CHANARIN, I | 1 |
| TENPAS, A | 1 |
| ABRAHAM, JP | 1 |
| JACKSON, N | 1 |
| DAVID, HL | 1 |
| Kublin, JG | 1 |
| Kamwendo, DS | 1 |
| Mukadam, RA | 1 |
| Chimpeni, P | 1 |
| Terlouw, DJ | 1 |
| Pfeiffer, CM | 1 |
| Shi, YP | 3 |
| Dhar, R | 1 |
| Rosen, DH | 2 |
| Nganda, RY | 1 |
| Reyburn, H | 1 |
| Marchant, T | 1 |
| Kodio, M | 1 |
| Coulibaly, D | 1 |
| Keita, AS | 1 |
| Maiga, B | 1 |
| Mungai, M | 1 |
| Parise, ME | 1 |
| Doumbo, O | 2 |
| Cusick, SE | 1 |
| Tielsch, JM | 1 |
| Ramsan, M | 1 |
| Jape, JK | 1 |
| Sazawal, S | 1 |
| Black, RE | 1 |
| Stoltzfus, RJ | 1 |
| Awine, T | 2 |
| Amponsa-Achiano, K | 1 |
| Jaffar, S | 1 |
| Baiden, R | 1 |
| Lemnge, MM | 1 |
| Ali, AS | 1 |
| Malecela, EK | 1 |
| Sambu, E | 1 |
| Abdulla, R | 1 |
| Juma, MS | 1 |
| Fakih, K | 1 |
| Abdulla, KH | 1 |
| Njau, RJ | 1 |
| Patrick Kachur, S | 1 |
| Schulden, J | 1 |
| Goodman, CA | 1 |
| Kassala, H | 1 |
| Elling, BF | 1 |
| Khatib, RA | 1 |
| Causer, LM | 1 |
| Mkikima, S | 1 |
| Abdulla, S | 1 |
| Bloland, PB | 2 |
| Mbaye, A | 2 |
| Richardson, K | 2 |
| Balajo, B | 2 |
| Dunyo, S | 2 |
| Shulman, C | 4 |
| Milligan, P | 3 |
| Walraven, G | 2 |
| Mulenga, M | 3 |
| Malunga, P | 1 |
| Bennett, S | 2 |
| Thuma, P | 1 |
| Fielding, K | 2 |
| Kone, M | 1 |
| Tolo, Y | 1 |
| Thera, MA | 1 |
| Sogoba, M | 1 |
| Fofana, M | 1 |
| Ouattara, A | 1 |
| Sissoko, M | 1 |
| Jansen, HF | 1 |
| Malunga, F | 1 |
| Thuma, PE | 3 |
| Alloueche, A | 1 |
| Shah, SN | 1 |
| Smith, EE | 1 |
| Obonyo, CO | 2 |
| Kain, KC | 1 |
| Ayisi, JG | 2 |
| Otieno, JA | 1 |
| Steketee, RW | 1 |
| Taylor, W | 1 |
| Ekvall, H | 1 |
| Kaneko, A | 1 |
| Ter Kuile, F | 1 |
| Olliaro, P | 1 |
| Bjorkman, A | 1 |
| Oloo, AJ | 1 |
| Bygbjerg, I | 1 |
| Mockenhaupt, FP | 2 |
| Reither, K | 1 |
| Zanger, P | 1 |
| Roepcke, F | 1 |
| Saad, E | 1 |
| Ziniel, P | 1 |
| Dzisi, SY | 1 |
| Frempong, M | 1 |
| Agana-Nsiire, P | 1 |
| Amoo-Sakyi, F | 1 |
| Otchwemah, R | 1 |
| Cramer, JP | 1 |
| Anemana, SD | 1 |
| Dietz, E | 1 |
| Bienzle, U | 2 |
| Kahigwa, E | 1 |
| Vountasou, P | 1 |
| Hommerich, L | 1 |
| von Oertzen, C | 1 |
| Bedu-Addo, G | 1 |
| Holmberg, V | 1 |
| Acquah, PA | 1 |
| Eggelte, TA | 1 |
| Gill, CJ | 2 |
| Macleod, WB | 2 |
| Mwanakasale, V | 2 |
| Chalwe, V | 2 |
| Mwananyanda, L | 2 |
| Champo, D | 2 |
| Mukwamataba, D | 2 |
| Chilengi, R | 2 |
| Thea, DM | 2 |
| Hamer, DH | 2 |
| Mubikayi, L | 1 |
| Mulele, CK | 1 |
| Gabor, J | 1 |
| Dornemann, J | 1 |
| Potschke, M | 1 |
| Oyakhirome, S | 1 |
| Kiessling, GC | 1 |
| Necek, M | 1 |
| Langin, MU | 1 |
| Klein Klouwenberg, P | 1 |
| Klopfer, A | 1 |
| Naumann, B | 1 |
| Altun, H | 1 |
| Agnandji, ST | 1 |
| Goesch, J | 1 |
| Decker, M | 1 |
| Salazar, CL | 1 |
| Supan, C | 1 |
| Kombila, DU | 1 |
| Borchert, L | 1 |
| Koster, KB | 1 |
| Adegnika, AA | 1 |
| Glasenapp, Iv | 1 |
| Ouma, P | 1 |
| Parise, M | 1 |
| Otieno, K | 1 |
| Tarimo, SD | 1 |
| Nahum, A | 1 |
| Erhart, A | 1 |
| Gazard, D | 1 |
| Agbowai, C | 1 |
| Van Overmeir, C | 1 |
| van Loen, H | 1 |
| Menten, J | 1 |
| Akogbeto, M | 1 |
| Coosemans, M | 1 |
| Dabo, CA | 1 |
| Saye, R | 1 |
| Yattara, O | 1 |
| Diarra, MA | 1 |
| Sangho, H | 1 |
| Bougouma, EC | 1 |
| Nébié, I | 1 |
| Asa, OO | 1 |
| Onayade, AA | 1 |
| Fatusi, AO | 1 |
| Ijadunola, KT | 1 |
| Abiona, TC | 1 |
| Cairns, M | 1 |
| Gosling, R | 1 |
| Deroń, Z | 1 |
| Jabłkowski, M | 1 |
| Phillips, RE | 1 |
| Verhoeff, FH | 1 |
| Masache, P | 1 |
| Kachale, B | 1 |
| Van der Kaay, HJ | 1 |
| Biemba, G | 2 |
| Gordeuk, VR | 2 |
| Mabeza, GF | 2 |
| Weiss, G | 1 |
| Shulman, CE | 2 |
| Dorman, EK | 1 |
| Cutts, F | 1 |
| Kawuondo, K | 1 |
| Bulmer, JN | 1 |
| Peshu, N | 1 |
| Marsh, K | 1 |
| Dolmans, DE | 1 |
| Parry, D | 1 |
| McLaren, CE | 1 |
| Okafor, HU | 1 |
| Nwaiwu, O | 1 |
| Harrison, KA | 1 |
| Ibeziako, PA | 1 |
| Tong, MJ | 1 |
| Strickland, GT | 1 |
| Votteri, BA | 1 |
| Gunning, JJ | 1 |
| Voller, A | 1 |
| Hawkey, CM | 1 |
| Richards, WH | 1 |
| Ridley, DS | 1 |
| Canfield, CJ | 1 |
| Keller, HI | 1 |
| Cirksena, WJ | 1 |
| Scheuer-Karpin, R | 1 |
| Topley, E | 2 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of the Safety and Efficacy of Mefloquine as Intermittent Preventive Treatment of Malaria in Pregnancy[NCT00811421] | 5,820 participants (Actual) | Interventional | 2009-09-30 | Completed | |||
| Scaling up the Use of Sulphadoxine-Pyrimethamine for the Preventive Treatment of Malaria in Pregnancy: Results and Lessons on Scalability, Costs and Program From Three Local Government Areas in Sokoto State, Nigeria[NCT02758353] | 31,493 participants (Actual) | Interventional | 2015-04-30 | Completed | |||
| Aetiology, Prevention and Control of Anaemia in Sub-Saharan Africa - Work Package 2: Efficacy Study: Efficacy of 2 Iron Fortified Porridges and IPT for the Prevention of Anemia in Young Children in Côte d'Ivoire.[NCT01634945] | 629 participants (Actual) | Interventional | 2012-04-30 | Completed | |||
| Intermittent Preventive Treatment in Schools: a Randomised Controlled Trial of the Impact of IPT on Malaria, Anaemia and Education Amongst Schoolchildren in Western Kenya[NCT00142246] | Phase 3 | 6,758 participants (Actual) | Interventional | 2005-01-31 | Completed | ||
| Effect of Intermittent Preventive Treatment (IPTp) With Sulfadoxine-Pyrimethamine Plus Insecticide Treated Nets, Delivered Through Antenatal Clinics for the Prevention of Malaria in Mozambican Pregnant Women[NCT00209781] | 1,028 participants | Interventional | 2003-08-31 | Active, not recruiting | |||
| Efficacy of Sulphadoxine-pyrimethamine and Amodiaquine Alone or in Combination as Intermittent Preventive Treatment in Pregnancy in the Kassena-Nankana District of Ghana: a Randomized Controlled Trial[NCT00146783] | Phase 2/Phase 3 | 3,642 participants (Actual) | Interventional | 2004-06-30 | Completed | ||
| A Study Of Impact Of Intermittent Preventive Treatment In Children With Amodiaquine Plus Artesunate Versus Sulphadoxine-Pyrimethamine On Hemoglobin Levels And Malaria Morbidity In Hohoe District Of Ghana[NCT00119132] | Phase 2/Phase 3 | 2,602 participants (Actual) | Interventional | 2005-06-30 | Completed | ||
| Assessing the Effectiveness of Community Delivery of Intermittent Preventive Treatment in Pregnancy (IPTp) in Malawi[NCT03376217] | 1,447 participants (Actual) | Interventional | 2017-12-01 | Completed | |||
| Effect of Single-course Malaria Chemoprevention on Clearance of and Protection From Plasmodium Falciparum Infection in the Presence of Resistance-associated Genotypes in Zambia[NCT06166498] | Phase 3 | 600 participants (Anticipated) | Interventional | 2024-02-15 | Not yet recruiting | ||
| Effect of Single-course Malaria Chemoprevention on Clearance of and Protection From Plasmodium Falciparum Infection in the Presence of Resistance-associated Genotypes in Cameroon[NCT06173206] | Phase 3 | 900 participants (Anticipated) | Interventional | 2024-03-15 | Not yet recruiting | ||
| A Longitudinal Study Assessing the Infectious Status and Immunity of Mothers and Their Children in Lambaréné, Including Intermittent Treatment of Children With Sulfadoxine-pyrimethamine for Malaria Control and Its Impact on Long-term Health[NCT00167843] | Phase 4 | 1,189 participants | Interventional | 2002-12-31 | Completed | ||
| Mass-Drug Administration With a Gametocytocidal Drug Combination, a Model for a Transmission Blocking Vaccine[NCT00509015] | 6,000 participants (Anticipated) | Interventional | 2008-02-29 | Completed | |||
| Evaluation of the Efficacy and Safety of Primaquine for Clearance of Gametocytes in Uncomplicated Falciparum Malaria in Uganda[NCT01365598] | Phase 3 | 468 participants (Actual) | Interventional | 2011-12-31 | Completed | ||
| Phase 2a Dose Escalation Study of the Efficacy, Safety, and Pharmacokinetics of Low Dose Primaquine for Gametocytocidal Activity Against P. Falciparum in Sub-Saharan Africa and South East Asia[NCT01743820] | Phase 2 | 81 participants (Actual) | Interventional | 2013-09-30 | Completed | ||
| Efficacy and Safety of Pediatric Immunization-linked Preventive Intermittent Treatment With Antimalarials in Decreasing Anemia and Malaria Morbidity in Rural Western Kenya[NCT00111163] | 1,516 participants | Interventional | 2004-03-31 | Completed | |||
| Chemoprophylaxis With Sulfadoxine-pyrimethamine to Prevent Recurrence of Severe Anaemia in Gambian Children Aged 3 Months to 9 Years[NCT00131716] | Phase 3 | 1,200 participants (Actual) | Interventional | 2003-05-31 | Completed | ||
| Improving Neonatal Health Through Rapid Malaria Testing in Early Pregnancy With High-Sensitivity[NCT05757167] | Phase 4 | 2,500 participants (Anticipated) | Interventional | 2023-11-06 | Recruiting | ||
| A Trial of the Combined Impact of Intermittent Preventive Treatment and Insecticide Treated Bednets in Reducing Morbidity From Malaria in African Children[NCT00738946] | 6,000 participants (Anticipated) | Interventional | 2008-08-31 | Completed | |||
| Effect of Prenatal Nutritional Supplementation on Birth Outcome in Hounde District, Burkina Faso[NCT00909974] | Phase 4 | 1,302 participants (Anticipated) | Interventional | 2006-02-28 | Completed | ||
| Intermittent Treatment With Sulfadoxine-pyrimethamine for Malaria Control in Infant: a Randomized, Double-blind, and Placebo-controlled Clinical Trial[NCT00206739] | Phase 4 | 1,070 participants (Actual) | Interventional | 2003-01-31 | Completed | ||
| Evaluation of the Safety and Effectiveness of EPI-linked Malaria Intermittent Chemotherapy and Iron Supplementation[NCT00857077] | 2,485 participants (Actual) | Interventional | 2000-09-30 | Completed | |||
| Dihydroartemisinin-Piperaquine or Sulphadoxine-Pyrimethamine for the Chemoprevention of Malaria in Children With Sickle Cell Anaemia in Eastern and Southern Africa: a Double Blind Randomised Trial (CHEMCHA)[NCT04844099] | Phase 3 | 723 participants (Actual) | Interventional | 2021-04-09 | Completed | ||
| Intermittent Preventive Treatment of Malaria With Sulfadoxine-Pyrimethamine in HIV-Seropositive and HIV-Seronegative Pregnant Women in Zambia[NCT00270530] | Phase 4 | 454 participants | Interventional | 2002-11-30 | Completed | ||
| A Comparative Assessment of the Efficacy of Fosmidomycin-Clindamycin Versus Sulfadoxine-Pyrimethamine for the Treatment of Children With Uncomplicated Plasmodium Falciparum Malaria[NCT00214643] | Phase 3 | 160 participants | Interventional | 2005-06-30 | Completed | ||
| Intermittent Preventive Treatment With Azithromycin-containing Regimens for the Prevention of Malarial Infections and Anaemia and the Control of Sexually Transmitted Infections in Pregnant Women in Papua New Guinea[NCT01136850] | Phase 3 | 2,793 participants (Actual) | Interventional | 2009-11-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
8 reviews available for pyrimethamine and Anemia
| Article | Year |
|---|---|
Recent work concerning anemia in the tropics.
Topics: Adolescent; Adult; Anemia; Anemia, Hypochromic; Anemia, Megaloblastic; Animals; Child; Child, Presch | 1982 |
Malaria in pregnancy control and pregnancy outcomes: a decade's overview using Ghana's DHIMS II data.
Topics: Anemia; Antimalarials; Birth Weight; Drug Combinations; Female; Ghana; Humans; Malaria; Pregnancy; P | 2022 |
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Topics: Anemia; Antimalarials; Birth Weight; Child; Child, Preschool; Dietary Supplements; Female; Folic Aci | 2022 |
Mefloquine for preventing malaria in pregnant women.
Topics: Anemia; Antimalarials; Drug Combinations; Drug Therapy, Combination; Female; HIV Seronegativity; Hum | 2018 |
A systematic review of the impact of malaria prevention in pregnancy on low birth weight and maternal anemia.
Topics: Africa South of the Sahara; Anemia; Antimalarials; Drug Combinations; Female; Humans; Infant, Low Bi | 2013 |
Cost-effectiveness of two versus three or more doses of intermittent preventive treatment for malaria during pregnancy in sub-Saharan Africa: a modelling study of meta-analysis and cost data.
Topics: Africa South of the Sahara; Anemia; Antimalarials; Cost-Benefit Analysis; Drug Combinations; Female; | 2015 |
Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials.
Topics: Africa; Anemia; Antimalarials; Double-Blind Method; Drug Administration Schedule; Drug Combinations; | 2009 |
Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials.
Topics: Africa; Anemia; Antimalarials; Double-Blind Method; Drug Administration Schedule; Drug Combinations; | 2009 |
Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials.
Topics: Africa; Anemia; Antimalarials; Double-Blind Method; Drug Administration Schedule; Drug Combinations; | 2009 |
Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials.
Topics: Africa; Anemia; Antimalarials; Double-Blind Method; Drug Administration Schedule; Drug Combinations; | 2009 |
Malaria in pregnancy: its relevance to safe-motherhood programmes.
Topics: Anemia; Antimalarials; Female; Health Policy; Humans; Kenya; Malaria; Pregnancy; Pregnancy Complicat | 1999 |
63 trials available for pyrimethamine and Anemia
| Article | Year |
|---|---|
Overall and Gender-Specific Effects of Intermittent Preventive Treatment of Malaria with Artemisinin-Based Combination Therapies among Schoolchildren in Mali: A Three-Group Open Label Randomized Controlled Trial.
Topics: Amodiaquine; Anemia; Antimalarials; Artemisinins; Artesunate; Child; Drug Combinations; Drug Therapy | 2022 |
Effectiveness of Intermittent Screening and Treatment of Malaria in Pregnancy on Maternal and Birth Outcomes in Selected Districts in Rwanda: A Cluster Randomized Controlled Trial.
Topics: Anemia; Antimalarials; Birth Weight; Drug Combinations; Female; Humans; Infant, Newborn; Malaria; Pl | 2023 |
Improving coverage of antenatal iron and folic acid supplementation and malaria prophylaxis through targeted information and home deliveries in Côte d'Ivoire: a cluster randomised controlled trial.
Topics: Adolescent; Anemia; Cote d'Ivoire; Dietary Supplements; Drug Combinations; Female; Folic Acid; Human | 2023 |
Microscopic and submicroscopic Plasmodium falciparum infection, maternal anaemia and adverse pregnancy outcomes in Papua New Guinea: a cohort study.
Topics: Adult; Anemia; Anti-Bacterial Agents; Antimalarials; Artemisinins; Asymptomatic Infections; Azithrom | 2019 |
Blood oxidative stress markers and Plasmodium falciparum malaria in non-immune African children.
Topics: Aldehydes; Anemia; Antigens, Protozoan; Antimalarials; Artemisinins; Biomarkers; Child, Preschool; D | 2014 |
Intermittent preventive treatment of malaria with sulphadoxine-pyrimethamine during pregnancy in Burkina Faso: effect of adding a third dose to the standard two-dose regimen on low birth weight, anaemia and pregnancy outcomes.
Topics: Adolescent; Adult; Anemia; Antimalarials; Burkina Faso; Drug Combinations; Female; Humans; Infant, L | 2010 |
Mefloquine Versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment in Pregnancy: A Joint Analysis on Efficacy and Tolerability.
Topics: Anemia; Antimalarials; Benin; Drug Combinations; Female; Humans; Infant, Low Birth Weight; Malaria; | 2015 |
The effect of iron-fortified complementary food and intermittent preventive treatment of malaria on anaemia in 12- to 36-month-old children: a cluster-randomised controlled trial.
Topics: Amodiaquine; Anemia; Antimalarials; Child, Preschool; Cote d'Ivoire; Diphosphates; Drug Combinations | 2015 |
Malaria illness mediated by anaemia lessens cognitive development in younger Ugandan children.
Topics: Age Factors; Anemia; Antimalarials; Artemisinins; Child, Preschool; Cognition; Cognition Disorders; | 2016 |
Efficacy and safety of intermittent preventive treatment in schoolchildren with sulfadoxine/pyrimethamine (SP) and SP plus piperaquine in Democratic Republic of the Congo: a randomised controlled trial.
Topics: Adolescent; Anemia; Antimalarials; Chemoprevention; Child; Child, Preschool; Democratic Republic of | 2017 |
Effect of intermittent preventive treatment of malaria on health and education in schoolchildren: a cluster-randomised, double-blind, placebo-controlled trial.
Topics: Adolescent; Amodiaquine; Anemia; Animals; Antimalarials; Child; Child, Preschool; Cluster Analysis; | 2008 |
Mother-to-child transmission of HIV-1: association with malaria prevention, anaemia and placental malaria.
Topics: Adult; Anemia; Anti-HIV Agents; Antimalarials; CD4 Lymphocyte Count; Drug Combinations; Female; HIV | 2008 |
A randomized, controlled trial of intermittent preventive treatment with sulfadoxine-pyrimethamine, amodiaquine, or the combination in pregnant women in Ghana.
Topics: Amodiaquine; Anemia; Animals; Antimalarials; Child, Preschool; Drug Combinations; Drug Therapy, Comb | 2008 |
Seasonal intermittent preventive treatment for the prevention of anaemia and malaria in Ghanaian children: a randomized, placebo controlled trial.
Topics: Amodiaquine; Anemia; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Drug Combinations; G | 2008 |
Individual efficacy of intermittent preventive treatment with sulfadoxine-pyrimethamine in primi- and secundigravidae in rural Burkina Faso: impact on parasitaemia, anaemia and birth weight.
Topics: Adult; Anemia; Animals; Antimalarials; Birth Weight; Burkina Faso; Drug Combinations; Female; Humans | 2009 |
Intermittent preventive treatment using artemisinin-based combination therapy reduces malaria morbidity among school-aged children in Mali.
Topics: Adolescent; Anemia; Artemisinins; Artesunate; Child; Drug Combinations; Drug Therapy, Combination; F | 2009 |
No rebound of morbidity following intermittent preventive sulfadoxine-pyrimethamine treatment of malaria in infants in Gabon.
Topics: Anemia; Antimalarials; Child, Preschool; Cohort Studies; Double-Blind Method; Drug Administration Sc | 2009 |
In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals.
Topics: Anemia; Anti-Infective Agents; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Dru | 2010 |
In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals.
Topics: Anemia; Anti-Infective Agents; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Dru | 2010 |
In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals.
Topics: Anemia; Anti-Infective Agents; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Dru | 2010 |
In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals.
Topics: Anemia; Anti-Infective Agents; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Dru | 2010 |
In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals.
Topics: Anemia; Anti-Infective Agents; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Dru | 2010 |
In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals.
Topics: Anemia; Anti-Infective Agents; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Dru | 2010 |
In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals.
Topics: Anemia; Anti-Infective Agents; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Dru | 2010 |
In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals.
Topics: Anemia; Anti-Infective Agents; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Dru | 2010 |
In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals.
Topics: Anemia; Anti-Infective Agents; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Dru | 2010 |
Intermittent preventive treatment in infants for the prevention of malaria in rural Western kenya: a randomized, double-blind placebo-controlled trial.
Topics: Anemia; Antimalarials; Artemisinins; Artesunate; Dapsone; Double-Blind Method; Drug Combinations; Hu | 2010 |
Prevention of the recurrence of anaemia in Gambian children following discharge from hospital.
Topics: Anemia; Animals; Antimalarials; Drug Combinations; Drug Resistance; Drug-Related Side Effects and Ad | 2010 |
Cost effectiveness of seasonal intermittent preventive treatment using amodiaquine & artesunate or sulphadoxine-pyrimethamine in Ghanaian children.
Topics: Amodiaquine; Anemia; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Cost-Benefit Analysi | 2010 |
A comparison of iron and folate with folate alone in hematologic recovery of children treated for acute malaria.
Topics: Anemia; Antimalarials; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; | 2010 |
Evaluating the effectiveness of IPTi on malaria using routine health information from sentinel health centres in southern Tanzania.
Topics: Anemia; Antimalarials; Comorbidity; Drug Administration Schedule; Drug Combinations; Female; Humans; | 2011 |
[Pharmacovigilance and impact of intermittent preventive treatment with sulfadoxine-pyrimethamine in pregnant women in Sélingué, Mali].
Topics: Adolescent; Adult; Anemia; Antimalarials; Drug Administration Schedule; Drug Combinations; Endemic D | 2010 |
Superiority of 3 over 2 doses of intermittent preventive treatment with sulfadoxine-pyrimethamine for the prevention of malaria during pregnancy in mali: a randomized controlled trial.
Topics: Adolescent; Adult; Anemia; Antimalarials; Chemoprevention; Drug Combinations; Female; Humans; Infant | 2011 |
Morbidity from malaria in children in the year after they had received intermittent preventive treatment of malaria: a randomised trial.
Topics: Amodiaquine; Anemia; Antimalarials; Body Weight; Burkina Faso; Child, Preschool; Double-Blind Method | 2011 |
Malaria morbidity in children in the year after they had received intermittent preventive treatment of malaria in Mali: a randomized control trial.
Topics: Amodiaquine; Anemia; Antimalarials; Body Weight; Child, Preschool; Drug Administration Schedule; Dru | 2011 |
Impact of combining intermittent preventive treatment with home management of malaria in children less than 10 years in a rural area of Senegal: a cluster randomized trial.
Topics: Amodiaquine; Anemia; Animals; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; C | 2011 |
An analysis of timing and frequency of malaria infection during pregnancy in relation to the risk of low birth weight, anaemia and perinatal mortality in Burkina Faso.
Topics: Adult; Anemia; Antimalarials; Burkina Faso; Drug Administration Schedule; Drug Combinations; Female; | 2012 |
Effectiveness of routine antihelminthic treatment on anaemia in pregnancy in Rufiji District, Tanzania: a cluster randomised controlled trial.
Topics: Adult; Albendazole; Anemia; Anemia, Iron-Deficiency; Anthelmintics; Antimalarials; Cluster Analysis; | 2011 |
Intermittent administration of iron and sulfadoxine-pyrimethamine to control anaemia in Kenyan children: a randomised controlled trial.
Topics: Anemia; Anthropometry; Antimalarials; Double-Blind Method; Drug Combinations; Female; Hemoglobins; H | 2002 |
Chloroquine and sulphadoxine-pyrimethamine efficacy for uncomplicated malaria treatment and haematological recovery in children in Bobo-Dioulasso, Burkina Faso during a 3-year period 1998-2000.
Topics: Anemia; Animals; Antimalarials; Burkina Faso; Child, Preschool; Chloroquine; Drug Combinations; Drug | 2002 |
Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine-pyrimethamine for the treatment of mild childhood anemia in western Kenya.
Topics: Anemia; Child, Preschool; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; | 2003 |
Relation between the response to iron supplementation and sickle cell hemoglobin phenotype in preschool children in western Kenya.
Topics: Anemia; Antimalarials; Child, Preschool; Dietary Supplements; Disease Susceptibility; Double-Blind M | 2004 |
Daily iron supplementation is more efficacious than twice weekly iron supplementation for the treatment of childhood anemia in western Kenya.
Topics: Anemia; Antimalarials; Child, Preschool; Dietary Supplements; Drug Administration Schedule; Drug Com | 2004 |
Comparison of intermittent preventive treatment with chemoprophylaxis for the prevention of malaria during pregnancy in Mali.
Topics: Abortion, Spontaneous; Adolescent; Adult; Anemia; Birth Weight; Chemoprevention; Chloroquine; Drug A | 2005 |
Short-term effects of vitamin A and antimalarial treatment on erythropoiesis in severely anemic Zanzibari preschool children.
Topics: Anemia; Antimalarials; C-Reactive Protein; Child, Preschool; Drug Combinations; Erythropoiesis; Eryt | 2005 |
Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana.
Topics: Anemia; Antimalarials; Cluster Analysis; Drug Combinations; Ghana; Hospitalization; Humans; Incidenc | 2005 |
Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana.
Topics: Anemia; Antimalarials; Cluster Analysis; Drug Combinations; Ghana; Hospitalization; Humans; Incidenc | 2005 |
Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana.
Topics: Anemia; Antimalarials; Cluster Analysis; Drug Combinations; Ghana; Hospitalization; Humans; Incidenc | 2005 |
Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana.
Topics: Anemia; Antimalarials; Cluster Analysis; Drug Combinations; Ghana; Hospitalization; Humans; Incidenc | 2005 |
Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana.
Topics: Anemia; Antimalarials; Cluster Analysis; Drug Combinations; Ghana; Hospitalization; Humans; Incidenc | 2005 |
Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana.
Topics: Anemia; Antimalarials; Cluster Analysis; Drug Combinations; Ghana; Hospitalization; Humans; Incidenc | 2005 |
Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana.
Topics: Anemia; Antimalarials; Cluster Analysis; Drug Combinations; Ghana; Hospitalization; Humans; Incidenc | 2005 |
Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana.
Topics: Anemia; Antimalarials; Cluster Analysis; Drug Combinations; Ghana; Hospitalization; Humans; Incidenc | 2005 |
Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana.
Topics: Anemia; Antimalarials; Cluster Analysis; Drug Combinations; Ghana; Hospitalization; Humans; Incidenc | 2005 |
Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana.
Topics: Anemia; Antimalarials; Cluster Analysis; Drug Combinations; Ghana; Hospitalization; Humans; Incidenc | 2005 |
Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana.
Topics: Anemia; Antimalarials; Cluster Analysis; Drug Combinations; Ghana; Hospitalization; Humans; Incidenc | 2005 |
Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana.
Topics: Anemia; Antimalarials; Cluster Analysis; Drug Combinations; Ghana; Hospitalization; Humans; Incidenc | 2005 |
Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana.
Topics: Anemia; Antimalarials; Cluster Analysis; Drug Combinations; Ghana; Hospitalization; Humans; Incidenc | 2005 |
Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana.
Topics: Anemia; Antimalarials; Cluster Analysis; Drug Combinations; Ghana; Hospitalization; Humans; Incidenc | 2005 |
Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana.
Topics: Anemia; Antimalarials; Cluster Analysis; Drug Combinations; Ghana; Hospitalization; Humans; Incidenc | 2005 |
Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana.
Topics: Anemia; Antimalarials; Cluster Analysis; Drug Combinations; Ghana; Hospitalization; Humans; Incidenc | 2005 |
Therapeutic efficacy of sulfadoxine-pyrimethamine and amodiaquine among children with uncomplicated Plasmodium falciparum malaria in Zanzibar, Tanzania.
Topics: Amodiaquine; Anemia; Animals; Antimalarials; Child, Preschool; Drug Combinations; Drug Resistance; H | 2005 |
Lack of inhibition of the anti-malarial action of sulfadoxine-pyrimethamine by folic acid supplementation when used for intermittent preventive treatment in Gambian primigravidae.
Topics: Adolescent; Adult; Anemia; Animals; Antimalarials; Dietary Supplements; Drug Combinations; Female; F | 2006 |
Folic acid treatment of Zambian children with moderate to severe malaria anemia.
Topics: Anemia; Animals; Antimalarials; Atovaquone; Child; Child, Preschool; Drug Combinations; Folic Acid; | 2006 |
A randomized, placebo-controlled trial of intermittent preventive treatment with sulphadoxine-pyrimethamine in Gambian multigravidae.
Topics: Adolescent; Adult; Anemia; Antimalarials; Bedding and Linens; Drug Combinations; Female; Gambia; Gra | 2006 |
A randomized trial of artesunate-sulfamethoxypyrazine-pyrimethamine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali.
Topics: Adolescent; Adult; Anemia; Antimalarials; Artemether; Artemisinins; Artesunate; Carrier State; Child | 2006 |
A randomised, double-blind, placebo-controlled trial of atovaquone-proguanil vs. sulphadoxine-pyrimethamine in the treatment of malarial anaemia in Zambian children.
Topics: Anemia; Antimalarials; Atovaquone; Child; Child, Preschool; Double-Blind Method; Drug Combinations; | 2006 |
Effect of artesunate plus sulfadoxine-pyrimethamine on haematological recovery and anaemia, in Kenyan children with uncomplicated, Plasmodium falciparum malaria.
Topics: Anemia; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Drug Combinations; Female; Humans | 2007 |
Intermittent preventive treatment of malaria in pregnancy: a community-based delivery system and its effect on parasitemia, anemia and low birth weight in Uganda.
Topics: Adolescent; Adult; Anemia; Antimalarials; Case-Control Studies; Community Health Workers; Drug Admin | 2008 |
Intermittent preventive treatment in infants as a means of malaria control: a randomized, double-blind, placebo-controlled trial in northern Ghana.
Topics: Anemia; Antimalarials; Data Interpretation, Statistical; Double-Blind Method; Drug Combinations; Fem | 2007 |
Intermittent preventive treatment in infants as a means of malaria control: a randomized, double-blind, placebo-controlled trial in northern Ghana.
Topics: Anemia; Antimalarials; Data Interpretation, Statistical; Double-Blind Method; Drug Combinations; Fem | 2007 |
Intermittent preventive treatment in infants as a means of malaria control: a randomized, double-blind, placebo-controlled trial in northern Ghana.
Topics: Anemia; Antimalarials; Data Interpretation, Statistical; Double-Blind Method; Drug Combinations; Fem | 2007 |
Intermittent preventive treatment in infants as a means of malaria control: a randomized, double-blind, placebo-controlled trial in northern Ghana.
Topics: Anemia; Antimalarials; Data Interpretation, Statistical; Double-Blind Method; Drug Combinations; Fem | 2007 |
Age interactions in the development of naturally acquired immunity to Plasmodium falciparum and its clinical presentation.
Topics: Age Factors; Anemia; Animals; Antigens, Protozoan; Child, Preschool; Dapsone; Drug Therapy, Combinat | 2007 |
Inferiority of single-dose sulfadoxine-pyrimethamine intermittent preventive therapy for malaria during pregnancy among HIV-positive Zambian women.
Topics: Adult; AIDS-Related Opportunistic Infections; Anemia; Antimalarials; Birth Weight; Double-Blind Meth | 2007 |
Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-seropositive pregnant Zambian women.
Topics: Adult; AIDS-Related Opportunistic Infections; Anemia; Antimalarials; Birth Weight; Double-Blind Meth | 2007 |
Intermittent preventive treatment against malaria in infants in Gabon--a randomized, double-blind, placebo-controlled trial.
Topics: Anemia; Antimalarials; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; | 2007 |
Intermittent preventive treatment against malaria in infants in Gabon--a randomized, double-blind, placebo-controlled trial.
Topics: Anemia; Antimalarials; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; | 2007 |
Intermittent preventive treatment against malaria in infants in Gabon--a randomized, double-blind, placebo-controlled trial.
Topics: Anemia; Antimalarials; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; | 2007 |
Intermittent preventive treatment against malaria in infants in Gabon--a randomized, double-blind, placebo-controlled trial.
Topics: Anemia; Antimalarials; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; | 2007 |
Intermittent preventive treatment against malaria in infants in Gabon--a randomized, double-blind, placebo-controlled trial.
Topics: Anemia; Antimalarials; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; | 2007 |
Intermittent preventive treatment against malaria in infants in Gabon--a randomized, double-blind, placebo-controlled trial.
Topics: Anemia; Antimalarials; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; | 2007 |
Intermittent preventive treatment against malaria in infants in Gabon--a randomized, double-blind, placebo-controlled trial.
Topics: Anemia; Antimalarials; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; | 2007 |
Intermittent preventive treatment against malaria in infants in Gabon--a randomized, double-blind, placebo-controlled trial.
Topics: Anemia; Antimalarials; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; | 2007 |
Intermittent preventive treatment against malaria in infants in Gabon--a randomized, double-blind, placebo-controlled trial.
Topics: Anemia; Antimalarials; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; | 2007 |
Malaria and anaemia among pregnant women at first antenatal clinic visit in Kisumu, western Kenya.
Topics: Adolescent; Adult; Anemia; Antimalarials; Bedding and Linens; Drug Combinations; Female; Humans; Ins | 2007 |
Adding artesunate to sulphadoxine-pyrimethamine greatly improves the treatment efficacy in children with uncomplicated falciparum malaria on the coast of Benin, West Africa.
Topics: Analysis of Variance; Anemia; Animals; Antimalarials; Artemisinins; Artesunate; Benin; Child, Presch | 2007 |
[Randomized clinical trial of two malaria prophylaxis regimens for pregnant women in Faladie, Mali].
Topics: Adult; Anemia; Antimalarials; Chloroquine; Drug Combinations; Endemic Diseases; Female; Humans; Infa | 2007 |
[Comparative impact of three malaria preventive regimens during pregnancy on maternal anemia due to malaria in Burkina Faso].
Topics: Adult; Anemia; Antimalarials; Burkina Faso; Chloroquine; Drug Therapy, Combination; Female; Humans; | 2008 |
Efficacy of intermittent preventive treatment of malaria with sulphadoxine-pyrimethamine in preventing anaemia in pregnancy among Nigerian women.
Topics: Adolescent; Adult; Anemia; Antimalarials; Chloroquine; Drug Combinations; Female; Humans; Malaria; N | 2008 |
Duration of protection against malaria and anaemia provided by intermittent preventive treatment in infants in Navrongo, Ghana.
Topics: Anemia; Drug Administration Schedule; Drug Combinations; Ghana; Humans; Infant; Malaria; Placebos; P | 2008 |
Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial.
Topics: Anemia; Antimalarials; Bedding and Linens; Double-Blind Method; Drug Administration Schedule; Drug C | 1999 |
Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial.
Topics: Anemia; Antimalarials; Bedding and Linens; Double-Blind Method; Drug Administration Schedule; Drug C | 1999 |
Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial.
Topics: Anemia; Antimalarials; Bedding and Linens; Double-Blind Method; Drug Administration Schedule; Drug C | 1999 |
Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial.
Topics: Anemia; Antimalarials; Bedding and Linens; Double-Blind Method; Drug Administration Schedule; Drug C | 1999 |
A prospective study of combination antimalarial therapy and of anaemia in Zambian children with cerebral malaria.
Topics: Anemia; Antimalarials; Child; Child, Preschool; Drug Therapy, Combination; Follow-Up Studies; Humans | 1999 |
Anemia of persistent malarial parasitemia in Nigerian children.
Topics: Anemia; Antimalarials; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Hu | 2001 |
Supplemental folates in the therapy of Plasmodium falciparum malaria.
Topics: Administration, Oral; Anemia; Antimalarials; Blood Platelets; Chloroquine; Clinical Trials as Topic; | 1970 |
Erythrokinetics during treatment of acute falciparum malaria.
Topics: Adult; Anemia; Clinical Trials as Topic; Erythropoiesis; Humans; Leucovorin; Malaria; Male; Military | 1971 |
Common anaemia in rural Gambia. I. Hookworm anaemia among men.
Topics: Adolescent; Adult; Anemia; Folic Acid; Folic Acid Deficiency; Gambia; Hemoglobins; Hookworm Infectio | 1968 |
50 other studies available for pyrimethamine and Anemia
| Article | Year |
|---|---|
Prevalence and risk factors of malaria and anaemia and the impact of preventive methods among pregnant women: A case study at the Akatsi South District in Ghana.
Topics: Anemia; Antimalarials; Cross-Sectional Studies; Drug Combinations; Female; Ghana; Humans; Malaria; P | 2022 |
High burden of asymptomatic malaria and anaemia despite high adherence to malaria control measures: a cross-sectional study among pregnant women across two seasons in a malaria-endemic setting in Ghana.
Topics: Anemia; Antimalarials; Cross-Sectional Studies; Female; Ghana; Humans; Infant, Newborn; Malaria; Mal | 2023 |
Intermittent preventive treatment comparing two versus three doses of sulphadoxine pyrimethamine (IPTp-SP) in the prevention of anaemia in pregnancy in Ghana: A cross-sectional study.
Topics: Adult; Anemia; Antimalarials; Cross-Sectional Studies; Drug Combinations; Educational Status; Female | 2021 |
High folate levels are not associated with increased malaria risk but with reduced anaemia rates in the context of high-dosed folate supplements and intermittent preventive treatment against malaria in pregnancy with sulphadoxine-pyrimethamine in Benin.
Topics: Anemia; Benin; Cohort Studies; Dietary Supplements; Drug Combinations; Female; Folic Acid; Humans; M | 2018 |
Adverse birth outcomes among mothers who received intermittent preventive treatment with Sulphadoxine-Pyrimethamine in the low malaria transmission region.
Topics: Adolescent; Adult; Anemia; Antimalarials; Cross-Sectional Studies; Drug Combinations; Female; Humans | 2019 |
[Prevalence of Plasmodium falciparum, anemia and molecular markers of chloroquine and sulfadoxine-pyriméthamine resistance in delivered women in Fana, Mali].
Topics: Adolescent; Adult; Anemia; Chloroquine; Delivery, Obstetric; Drug Combinations; Drug Resistance; Fem | 2013 |
Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on placental malaria, maternal anaemia and birthweight in areas with high and low malaria transmission intensity in Tanzania.
Topics: Adult; Anemia; Antimalarials; Birth Weight; Drug Combinations; Female; Humans; Infant, Low Birth Wei | 2014 |
Prevalence and risk factors for Plasmodium falciparum malaria in pregnant women attending antenatal clinic in Bobo-Dioulasso (Burkina Faso).
Topics: Adolescent; Adult; Age Factors; Anemia; Antimalarials; Burkina Faso; Cross-Sectional Studies; Drug C | 2014 |
Assessment of the usage and effectiveness of intermittent preventive treatment and insecticide-treated nets on the indicators of malaria among pregnant women attending antenatal care in the Buea Health District, Cameroon.
Topics: Adolescent; Adult; Anemia; Antimalarials; Blood; Cameroon; Chemoprevention; Cross-Sectional Studies; | 2016 |
Decrease of microscopic Plasmodium falciparum infection prevalence during pregnancy following IPTp-SP implementation in urban cities of Gabon.
Topics: Adult; Anemia; Antimalarials; Birth Weight; Cities; Cross-Sectional Studies; Drug Combinations; Fema | 2016 |
Recent uptake of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine is associated with increased prevalence of Pfdhfr mutations in Bobo-Dioulasso, Burkina Faso.
Topics: Adolescent; Adult; Anemia; Antimalarials; Burkina Faso; Drug Combinations; Female; Hemoglobins; Huma | 2017 |
Intermittent preventive treatment of malaria in pregnancy: the incremental cost-effectiveness of a new delivery system in Uganda.
Topics: Adolescent; Anemia; Animals; Antimalarials; Community Health Services; Cost-Benefit Analysis; Drug C | 2008 |
Intermittent preventive treatment for malaria and anaemia control in Tanzanian infants; the development and implementation of a public health strategy.
Topics: Anemia; Antimalarials; Child, Preschool; Delivery of Health Care; Female; Health Knowledge, Attitude | 2009 |
Costs and cost-effectiveness of delivering intermittent preventive treatment through schools in western Kenya.
Topics: Anemia; Antimalarials; Chemoprevention; Communicable Disease Control; Cost-Benefit Analysis; Drug Co | 2008 |
Intermittent preventive treatment with antimalarial drugs.
Topics: Amodiaquine; Anemia; Antimalarials; Drug Administration Schedule; Drug Combinations; Humans; Infant; | 2009 |
Community-based distribution of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy improved coverage but reduced antenatal attendance in southern Malawi.
Topics: Adolescent; Adult; Anemia; Antimalarials; Birth Weight; Community Health Services; Drug Combinations | 2009 |
Burden of malaria during pregnancy at the time of IPTp/SP implementation in Gabon.
Topics: Adolescent; Adult; Age Distribution; Anemia; Antimalarials; Cross-Sectional Studies; Drug Combinatio | 2010 |
Trends in pregnancy outcomes in Malawian adolescents receiving antimalarial and hematinic supplements.
Topics: Adolescent; Adult; Anemia; Antimalarials; Cross-Sectional Studies; Delivery, Obstetric; Drug Combina | 2010 |
Sulfadoxine-pyrimethamine-based intermittent preventive treatment, bed net use, and antenatal care during pregnancy: demographic trends and impact on the health of newborns in the Kassena Nankana District, northeastern Ghana.
Topics: Anemia; Antimalarials; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; F | 2010 |
Efficacy of intermittent preventive treatment with sulfadoxine-pyrimethamine on placental parasitemia in pregnant women in midwestern Nigeria.
Topics: Adult; Anemia; Antimalarials; Cohort Studies; Drug Combinations; Female; Humans; Infant, Low Birth W | 2011 |
Marked reduction in prevalence of malaria parasitemia and anemia in HIV-infected pregnant women taking cotrimoxazole with or without sulfadoxine-pyrimethamine intermittent preventive therapy during pregnancy in Malawi.
Topics: Adolescent; Adult; Anemia; Antimalarials; Chemoprevention; Cross-Sectional Studies; Drug Combination | 2011 |
Intermittent preventive treatment with sulfadoxine-pyrimethamine against malaria and anemia in pregnant women.
Topics: Adolescent; Adult; Anemia; Antimalarials; Drug Combinations; Female; Humans; Malaria; Pregnancy; Pre | 2011 |
Quantification of the burden and consequences of pregnancy-associated malaria in the Democratic Republic of the Congo.
Topics: Anemia; Antimalarials; Birth Weight; Cross-Sectional Studies; Democratic Republic of the Congo; Drug | 2011 |
The effectiveness and perception of the use of sulphadoxine-pyrimethamine in intermittent preventive treatment of malaria in pregnancy programme in Offinso district of Ashanti region, Ghana.
Topics: Adult; Anemia; Antimalarials; Cross-Sectional Studies; Drug Administration Schedule; Drug Combinatio | 2011 |
Clinical manifestations of new versus recrudescent malaria infections following anti-malarial drug treatment.
Topics: Anemia; Antimalarials; Child; Child, Preschool; Clinical Trials as Topic; Drug Combinations; Fever; | 2012 |
Anaemia in African children: malaria or iron deficiency?
Topics: Africa; Anemia; Anemia, Iron-Deficiency; Antimalarials; Child, Preschool; Drug Combinations; Humans; | 2003 |
[Severe anemia caused by pyrimethamine therapy of polycythemia].
Topics: Anemia; Antimalarials; Humans; Polycythemia; Polycythemia Vera; Pyrimethamine | 1958 |
[Polycythemia vera in an 11-year-old child. Bone marrow depression after daraprim treatment].
Topics: Anemia; Anemia, Aplastic; Antimalarials; Bone Marrow; Child; Depression; Humans; Infant; Pancytopeni | 1961 |
[Megaloblastic anemias with peripheral micro-and macroplania in daraprim therapy of polycythemia vera].
Topics: Anemia; Anemia, Megaloblastic; Antimalarials; Polycythemia Vera; Pyrimethamine; Tracheophyta | 1960 |
[A COMPARISON OF MEGALOBLASTIC MARROW CHANGES AFTER DARAPRIM THERAPY AND IN PERNICIOUS ANEMIA].
Topics: Anemia; Anemia, Aplastic; Anemia, Megaloblastic; Anemia, Pernicious; Blood Cell Count; Bone Marrow; | 1964 |
STUDIES IN DRUG-INDUCED MEGALOBLASTIC ANAEMIA.
Topics: Anemia; Anemia, Macrocytic; Anemia, Megaloblastic; Blood; Blood Cell Count; Geriatrics; Glutamates; | 1964 |
HEMATOLOGICAL SIDE-EFFECTS OF PYRIMETHAMINE IN THE TREATMENT OF OCULAR TOXOPLASMOSIS.
Topics: Anemia; Anemia, Macrocytic; Blood Platelets; Drug Therapy; Folic Acid; Hemoglobinometry; Humans; Leu | 1965 |
SOME EFFECTS OF PROCAINE PENICILLIN ON THE PYRIMETHAMINE-TREATED CHICK WITH SPECIAL REFERENCE TO ITS EFFECT ON OVIDUCT GROWTH INHIBITION.
Topics: Anemia; Anemia, Macrocytic; Animals; Chickens; DNA; Fallopian Tubes; Female; Organ Size; Oviducts; P | 1965 |
SOME FEATURES OF MALARIA IN DILI, PORTUGUESE TIMOR, DURING 1963-64.
Topics: Amodiaquine; Anemia; Chloroquine; Clinical Laboratory Techniques; Drug Therapy; Epidemiology; Humans | 1965 |
Sustained clinical efficacy of sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Malawi after 10 years as first line treatment: five year prospective study.
Topics: Adolescent; Adult; Aged; Anemia; Antimalarials; Child; Child, Preschool; Drug Combinations; Drug Eva | 2004 |
Knowledge of malaria influences the use of insecticide treated nets but not intermittent presumptive treatment by pregnant women in Tanzania.
Topics: Adult; Age Factors; Anemia; Antimalarials; Bedding and Linens; Drug Combinations; Educational Status | 2004 |
Prevalence of malaria parasitemia among clients seeking treatment for fever or malaria at drug stores in rural Tanzania 2004.
Topics: Adult; Amodiaquine; Analgesics, Non-Narcotic; Anemia; Antimalarials; Child, Preschool; Drug Combinat | 2006 |
HIV immunosuppression and antimalarial efficacy: sulfadoxine-pyrimethamine for the treatment of uncomplicated malaria in HIV-infected adults in Siaya, Kenya.
Topics: Adult; Anemia; Antimalarials; CD4 Lymphocyte Count; Drug Combinations; Female; Fever; HIV Infections | 2006 |
Effect of haematinic supplementation and malaria prevention on maternal anaemia and malaria in western Kenya.
Topics: Adult; Anemia; Antimalarials; Drug Combinations; Drug Therapy, Combination; Female; Folic Acid; Hema | 2007 |
Decline of placental malaria in southern Ghana after the implementation of intermittent preventive treatment in pregnancy.
Topics: Adolescent; Adult; Anemia; Animals; Antimalarials; Birth Weight; Chemoprevention; Drug Administratio | 2007 |
Appraisal on the prevalence of malaria and anaemia in pregnancy and factors influencing uptake of intermittent preventive therapy with sulfadoxine-pyrimethamine in Kibaha district, Tanzania.
Topics: Adolescent; Adult; Anemia; Antimalarials; Cross-Sectional Studies; Drug Combinations; Female; Humans | 2007 |
[Side effects of toxoplasmosis treatment].
Topics: Adolescent; Adult; Anemia; Antiprotozoal Agents; Child; Child, Preschool; Drug Eruptions; Dyspepsia; | 1980 |
Management of Plasmodium falciparum malaria.
Topics: Amodiaquine; Anemia; Antimalarials; Brain Diseases; Chloroquine; Drug Resistance; Female; Humans; Hy | 1984 |
Parasitological and haematological responses to treatment of Plasmodium falciparum malaria with sulphadoxine-pyrimethamine in southern Malawi.
Topics: Anemia; Antimalarials; Child, Preschool; Drug Combinations; Female; Follow-Up Studies; Hemoglobins; | 1997 |
Prolonged macrophage activation and persistent anaemia in children with complicated malaria.
Topics: Analysis of Variance; Anemia; Antimalarials; Child, Preschool; Deferoxamine; Drug Therapy, Combinati | 1998 |
Intermittent malaria treatment as a component of the EPI (Expanded Programme on Immunization) schedule in Africa.
Topics: Africa; Anemia; Antimalarials; Drug Administration Schedule; Drug Combinations; Humans; Immunization | 2002 |
Maternal anaemia and fetal birthweight.
Topics: Anemia; Anemia, Sickle Cell; Birth Weight; Blood Transfusion; Body Height; Chloroquine; Embryonic an | 1973 |
Human malaria (Plasmodium falciparum) in owl monkeys (Aotus trivirgatus).
Topics: Anemia; Animals; Antimalarials; Blood Coagulation; Haplorhini; Malaria; Myocardium; Plasmodium falci | 1969 |
[Distrubed granulocytopoiesis following administration of various drugs].
Topics: Adult; Aged; Agranulocytosis; Anemia; Antimetabolites; Bone Marrow Examination; Drug-Related Side Ef | 1969 |
Common anaemia in rural Gambia. 3. A spontaneously remitting anaemia possibly precipitated by malarial parasitaemia.
Topics: Adolescent; Anemia; Child; Child, Preschool; Female; Gambia; Hemoglobins; Humans; Infant; Infant, Ne | 1968 |